var title_f23_28_24000="Bifascicular block";
var content_f23_28_24000=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 631px\">",
"   <div class=\"ttl\">",
"    Bifascicular block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 611px; height: 313px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     By permission: Nathanson LA, McClennen S, Safran C, Goldberger AL. ECG Wave-Maven: Self-Assessment Program for Students and Clinicians.",
"     <a href=\"file://ecg.bidmc.harvard.edu\" target=\"_blank\">",
"      file://ecg.bidmc.harvard.edu",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24000=[""].join("\n");
var outline_f23_28_24000=null;
var title_f23_28_24001="Swollen gingival tissues";
var content_f23_28_24001=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gingivitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Red and swollen gingival tissues which bleed easily upon flossing and brushing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24001=[""].join("\n");
var outline_f23_28_24001=null;
var title_f23_28_24002="Patient information: Acute bronchitis (The Basics)";
var content_f23_28_24002=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15889\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"         Normal lungs",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?42/0/43011\">",
"         Patient information: Cough in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/7/13427\">",
"         Patient information: Cough in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/55/18291\">",
"         Patient information: Cough, runny nose, and the common cold (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/47/33522\">",
"         Patient information: Flu (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?8/57/9106\">",
"         Patient information: Acute bronchitis in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/34/28195\">",
"         Patient information: Chronic cough in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/12/35013\">",
"         Patient information: Influenza symptoms and treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?43/11/44210\">",
"         Patient information: The common cold in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Acute bronchitis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/acute-bronchitis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H30928682\">",
"      <span class=\"h1\">",
"       What is bronchitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bronchitis is an infection that causes a cough. It happens when the tubes that carry air into the lungs, called the &ldquo;bronchi,&rdquo; get infected (",
"      <a class=\"graphic graphic_figure graphicRef67527 \" href=\"UTD.htm?40/17/41237\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Usually, bronchitis happens when a person gets a cold or the flu. The viruses that cause the cold or flu infect the bronchi and irritate them.",
"     </p>",
"     <p>",
"      Bronchitis can also happen when a person gets an infection called &ldquo;whooping cough,&rdquo; but this is not as common. Whooping cough is caused by bacteria that can infect the bronchi. Most people get vaccines that prevent whooping cough, but the vaccine doesn&rsquo;t always work. Sometimes, people still get the infection.",
"     </p>",
"     <p>",
"      This article covers &ldquo;acute&rdquo; bronchitis. This is different from &ldquo;chronic&rdquo; bronchitis, which is an illness in smokers who have a long-lasting cough.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30928689\">",
"      <span class=\"h1\">",
"       What are the symptoms of bronchitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common symptoms of bronchitis are:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A nagging cough that can last up to a few weeks",
"       </li>",
"       <li>",
"        Coughing up mucus that is clear, yellow, or green",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with bronchitis do not usually get a fever.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30928696\">",
"      <span class=\"h1\">",
"       When should I call the doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people who have a cough that lasts longer than their other cold or flu symptoms do not need to see a doctor. But you should call your doctor or nurse if you have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A fever higher than 100.4&deg;F (38&deg;C)",
"       </li>",
"       <li>",
"        A cough that lasts longer than 10 days",
"       </li>",
"       <li>",
"        Chest pain when you cough, trouble breathing, or coughing up blood",
"       </li>",
"       <li>",
"        A barking cough that makes it hard to talk",
"       </li>",
"       <li>",
"        A cough and weight loss that you cannot explain",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30928703\">",
"      <span class=\"h1\">",
"       Is there a test for bronchitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People do not usually need a test. But your doctor or nurse might do a test, such as a chest x-ray, if the cause of your cough isn&rsquo;t clear.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30928710\">",
"      <span class=\"h1\">",
"       How is bronchitis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors do not usually treat bronchitis with antibiotic medicines. That&rsquo;s because bronchitis is usually caused by a virus, and antibiotics kill bacteria&mdash;not viruses.",
"     </p>",
"     <p>",
"      To feel better, you can treat your cold and flu symptoms. Different treatments you can try include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Taking a pain-relieving medicine",
"       </li>",
"       <li>",
"        Taking over-the-counter cough and cold medicines",
"       </li>",
"       <li>",
"        Breathing in warm, moist air, such as in the shower, over a kettle, or from a humidifier",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30928717\">",
"      <span class=\"h1\">",
"       How can I keep from getting bronchitis again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chance of getting bronchitis again by keeping the germs that cause bronchitis out of your body. One of the best ways to do this is to wash your hands often with soap and water. If there is no sink nearby, you can use a hand gel with alcohol in it to clean your hands.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30928724\">",
"      <span class=\"h1\">",
"       How can I keep from spreading my germs?",
"      </span>",
"      &nbsp;&mdash;&nbsp;In addition to washing your hands often, you should cover your mouth with your elbow when you sneeze or cough. Using your elbow keeps you from getting germs on your hands. If you use a tissue, throw the tissue away and wash your hands.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H30928731\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/55/18291?source=see_link\">",
"       Patient information: Cough, runny nose, and the common cold (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/47/33522?source=see_link\">",
"       Patient information: Flu (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/0/43011?source=see_link\">",
"       Patient information: Cough in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=see_link\">",
"       Patient information: Cough in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/57/9106?source=see_link\">",
"       Patient information: Acute bronchitis in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44210?source=see_link\">",
"       Patient information: The common cold in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=see_link\">",
"       Patient information: Influenza symptoms and treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/34/28195?source=see_link\">",
"       Patient information: Chronic cough in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?23/28/24002?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15889 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-CCD5015BA2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24002=[""].join("\n");
var outline_f23_28_24002=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928682\">",
"      What is bronchitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928689\">",
"      What are the symptoms of bronchitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928696\">",
"      When should I call the doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928703\">",
"      Is there a test for bronchitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928710\">",
"      How is bronchitis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928717\">",
"      How can I keep from getting bronchitis again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928724\">",
"      How can I keep from spreading my germs?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30928731\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15889\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"      Normal lungs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/57/9106?source=related_link\">",
"      Patient information: Acute bronchitis in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/34/28195?source=related_link\">",
"      Patient information: Chronic cough in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/0/43011?source=related_link\">",
"      Patient information: Cough in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=related_link\">",
"      Patient information: Cough in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/55/18291?source=related_link\">",
"      Patient information: Cough, runny nose, and the common cold (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/47/33522?source=related_link\">",
"      Patient information: Flu (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=related_link\">",
"      Patient information: Influenza symptoms and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44210?source=related_link\">",
"      Patient information: The common cold in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_28_24003="Oral lichen planus - desquamative gingivitis";
var content_f23_28_24003=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Desquamative gingivitis in oral lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Extensive erosions are present on the gingiva.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Image created by Carl Allen, DDS, MSD. Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24003=[""].join("\n");
var outline_f23_28_24003=null;
var title_f23_28_24004="Magnesium chloride: Patient drug information";
var content_f23_28_24004=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Magnesium chloride: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/22/24933?source=see_link\">",
"     see \"Magnesium chloride: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/31/501?source=see_link\">",
"     see \"Magnesium chloride: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Chloromag&reg;;",
"     </li>",
"     <li>",
"      Mag 64&reg; [OTC];",
"     </li>",
"     <li>",
"      Mag Delay&trade; [OTC];",
"     </li>",
"     <li>",
"      Slow-Mag&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691572",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help growth and good health.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop and treat low magnesium levels.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to magnesium chloride or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2850019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Heart disease or kidney disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697314",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have nerve disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697716",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Try to space other drugs from this one by 2 hours. This drug stops many drugs from getting into the body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699028",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow enteric-coated and long-acting products whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor will give this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11214 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-AFBC45AB80-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24004=[""].join("\n");
var outline_f23_28_24004=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190783\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019018\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019017\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019022\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019023\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019025\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019020\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019021\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019026\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019027\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/22/24933?source=related_link\">",
"      Magnesium chloride: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/31/501?source=related_link\">",
"      Magnesium chloride: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_28_24005="Acetaminophen and codeine: Patient drug information";
var content_f23_28_24005=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Acetaminophen and codeine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/5/10328?source=see_link\">",
"     see \"Acetaminophen and codeine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/12/5319?source=see_link\">",
"     see \"Acetaminophen and codeine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F129491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Capital&reg; and Codeine;",
"     </li>",
"     <li>",
"      Tylenol&reg; with Codeine No. 3;",
"     </li>",
"     <li>",
"      Tylenol&reg; with Codeine No. 4",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F129492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      ratio-Emtec;",
"     </li>",
"     <li>",
"      ratio-Lenoltec;",
"     </li>",
"     <li>",
"      Triatec-30;",
"     </li>",
"     <li>",
"      Triatec-8;",
"     </li>",
"     <li>",
"      Triatec-8 Strong;",
"     </li>",
"     <li>",
"      Tylenol Elixir with Codeine;",
"     </li>",
"     <li>",
"      Tylenol No. 1;",
"     </li>",
"     <li>",
"      Tylenol No. 1 Forte;",
"     </li>",
"     <li>",
"      Tylenol No. 2 with Codeine;",
"     </li>",
"     <li>",
"      Tylenol No. 3 with Codeine;",
"     </li>",
"     <li>",
"      Tylenol No. 4 with Codeine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to acetaminophen, codeine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are addicted to drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701044",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink beer, wine, or mixed drinks or take any drugs that have alcohol.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696680",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid other sources of acetaminophen. An overdose may cause problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you use other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696699",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful if you have G6PD deficiency. Anemia may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3927405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug with other strong pain drugs or if you are using a pain patch without talking to your doctor first.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694768",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take more than what your doctor told you to take. Liver problems may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694267",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (elixir, suspension) if you cannot swallow pills. Shake suspension well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a pain diary.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12357 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-C801F8800B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24005=[""].join("\n");
var outline_f23_28_24005=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129491\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129492\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026553\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026552\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026557\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026558\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026560\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026555\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026556\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026561\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026562\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/5/10328?source=related_link\">",
"      Acetaminophen and codeine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/12/5319?source=related_link\">",
"      Acetaminophen and codeine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_28_24006="Tolosa-Hunt syndrome";
var content_f23_28_24006=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tolosa-Hunt syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/28/24006/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24006/contributors\">",
"     Kenneth S Shindler, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/28/24006/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24006/contributors\">",
"     Paul W Brazis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/28/24006/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24006/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/28/24006/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Tolosa-Hunt syndrome is a rare syndrome with an estimated annual incidence of one case per million per year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/1\">",
"     1",
"    </a>",
"    ]. It is characterized by painful ophthalmoplegia (weakness of the eye muscles) and is caused by an idiopathic granulomatous inflammation of the cavernous sinus. This syndrome was first described in 1954, and its exquisite responsiveness to glucocorticoid treatment was recognized a few years later [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While considered a benign condition, permanent neurologic deficits can occur, and relapses are common, often requiring prolonged immunosuppressive therapy. Tolosa-Hunt syndrome must be carefully differentiated from more malignant diagnoses, a mandate challenged by the lack of a specific diagnostic test abnormality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Tolosa-Hunt syndrome is caused by an inflammatory process of unknown etiology. On histopathology, there is a nonspecific inflammation of the septa and wall of the cavernous sinus, with a lymphocyte and plasma cell infiltration, giant cell granulomas, and proliferation of fibroblasts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The inflammation produces pressure and secondary dysfunction of the structures within the cavernous sinus, including cranial nerves III, IV, and VI, as well as the superior divisions of cranial nerve V.",
"   </p>",
"   <p>",
"    While reports of intracranial extension of the inflammation exist [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/1\">",
"     1",
"    </a>",
"    ], there are no reports of systemic involvement. Cases of Tolosa-Hunt syndrome have been reported in patients with other inflammatory disorders, such as systemic lupus erythematosus, but this may simply represent an association of the two autoimmune conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/5\">",
"     5",
"    </a>",
"    ]. Cases of orbital inflammation may be the initial presentation of systemic inflammatory disorders such as sarcoidosis and Wegener's granulomatosis (",
"    <a class=\"graphic graphic_table graphicRef77825 \" href=\"UTD.htm?3/54/3949\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/8/20616?source=see_link\">",
"     \"Neurologic sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link\">",
"     \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Headache Classification Subcommittee of the International Headache Society describes the course and features of Tolosa-Hunt syndrome as \"episodic orbital pain associated with paralysis of one or more of the third, fourth,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sixth cranial nerves which usually resolves spontaneously but tends to relapse and remit\" [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients may present at any age, from the first through the eighth decade of life [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Men and women are affected at the same frequency.",
"   </p>",
"   <p>",
"    Patients report a constant pain behind the eye that may begin several days (up to two weeks) prior to the ophthalmoplegia, or the pain may start after the cranial neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"     7",
"    </a>",
"    ]. The pain is characteristically described as a steady gnawing or boring pain. Tolosa-Hunt syndrome is typically unilateral; bilateral symptoms occur in 4 to 5 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diplopia results from cranial mono- or polyneuropathy. Involvement of cranial nerve III is reported most frequently (85 percent), followed by cranial nerve VI (70 percent), the ophthalmic division of cranial nerve V (30 percent), and cranial nerve IV (29 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/9\">",
"     9",
"    </a>",
"    ]. Involvement of periarterial sympathetic fibers causes a third order Horner's syndrome in approximately 20 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=see_link\">",
"     \"Horner's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In conjunction with ophthalmoplegia, the maxillary and mandibular divisions of the fifth nerve, the optic nerve, and the facial nerve have also been affected in individual cases, suggesting that inflammation extends beyond the cavernous sinus in rare cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/3,4,9,12-15\">",
"     3,4,9,12-15",
"    </a>",
"    ]. Involvement of the optic nerve occurs at the orbital apex and may cause optic disc edema or pallor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"     7",
"    </a>",
"    ]. Loss of visual acuity is uncommon but may occur unpredictably and may be permanent.",
"   </p>",
"   <p>",
"    Left untreated, symptoms of Tolosa-Hunt syndrome may resolve spontaneously after an average of about eight weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/3,7\">",
"     3,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients (greater than 75 percent) who present with painful ophthalmoplegia will not have Tolosa-Hunt syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The syndrome of painful ophthalmoplegia may be caused by any process exerting a mass effect on the cavernous sinus (",
"    <a class=\"graphic graphic_table graphicRef77825 \" href=\"UTD.htm?3/54/3949\">",
"     table 1",
"    </a>",
"    ). These include a primary intracranial tumor, lymphoma or other local or distant metastatic tumors, aneurysm, carotid-cavernous fistula, carotid dissection, cavernous sinus thrombosis, infection, vasculitis, and sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"     7",
"    </a>",
"    ]. Of these conditions, tumors are the most common (30 percent). In addition to these structural compressive lesions, painful ophthalmoplegia can also be caused by ophthalmoplegic migraine, giant cell arteritis, or a diabetic cranial nerve palsy.",
"   </p>",
"   <p>",
"    Orbital pseudotumor is a related condition of idiopathic inflammation involving the orbit [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/18\">",
"     18",
"    </a>",
"    ]. Patients present with painful ophthalmoplegia and orbital signs (proptosis, conjunctival injection, and chemosis). This condition, which is also glucocorticoid responsive, may be identical to Tolosa-Hunt syndrome, distinguished only by a different anatomic localization.",
"   </p>",
"   <p>",
"    In general, it is difficult to exclude alternative diagnoses clinically. Authors note that either a sudden or a gradual onset of symptoms can be observed in patients with aneurysm, tumor, as well as Tolosa-Hunt syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"     7",
"    </a>",
"    ]. Other clinical signs may be suggestive but are not completely reliable. Signs of orbital congestion (proptosis, conjunctival injection, and chemosis) usually accompany cavernous sinus thrombosis and diseases involving the orbit. Diabetic ophthalmoplegia usually results from a mononeuropathy rather than a polyneuropathy. Fever suggests infection but may not be present in patients with more indolent pathogens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of Tolosa-Hunt syndrome is based upon the clinical presentation in conjunction with neuroimaging results and a clinical response to corticosteroids. Laboratory tests and lumbar puncture are also recommended. Direct tissue biopsy is rarely performed due to the technically difficult and potentially harmful approach to the cavernous sinus.",
"   </p>",
"   <p>",
"    The specific diagnostic criteria recommended by the International Headache Society are summarized [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One or more episodes of unilateral orbital pain lasting for weeks (untreated)",
"     </li>",
"     <li>",
"      Third, fourth,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      sixth cranial nerve palsy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      granuloma detected by magnetic resonance imaging (MRI) or biopsy",
"     </li>",
"     <li>",
"      Cranial nerve palsy begins within two weeks of onset of orbital pain",
"     </li>",
"     <li>",
"      Symptoms resolve within 72 hours when treated with sufficient corticosteroids",
"     </li>",
"     <li>",
"      Other etiologies are excluded by appropriate investigation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A contrast-enhanced MRI is essential to the diagnostic evaluation of a patient with painful ophthalmoplegia, primarily to exclude other causes of painful ophthalmoplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/16\">",
"     16",
"    </a>",
"    ]. In patients with Tolosa-Hunt syndrome, MRI findings can include [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/11,19-22\">",
"     11,19-22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enlargement of the cavernous sinus with abnormal tissue that is usually isointense to gray matter on T1 and iso- or hypointense on T2, and strongly enhances with gadolinium",
"     </li>",
"     <li>",
"      Abnormal convexity of the wall of the cavernous sinus",
"     </li>",
"     <li>",
"      Focal narrowing of the intracavernous internal carotid artery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In rare cases of Tolosa-Hunt syndrome, the MRI is normal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/23\">",
"     23",
"    </a>",
"    ]. Computed tomography (CT) may also show cavernous sinus signal changes in Tolosa-Hunt syndrome, but is less sensitive than MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/11,19,24,25\">",
"     11,19,24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These MRI findings are not specific to Tolosa-Hunt syndrome. Similar findings are seen with other etiologies, such as lymphoma, sarcoidosis, and meningioma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"     7",
"    </a>",
"    ]. MRI findings in some of these disorders may also respond to glucocorticoid therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Blood and CSF evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the MRI is normal or shows changes consistent with cavernous sinus inflammation, further evaluation should include blood and cerebrospinal fluid (CSF) testing to exclude other possible causes of orbital inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"     7",
"    </a>",
"    ]. Recommended blood testing includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete blood count",
"     </li>",
"     <li>",
"      Electrolytes",
"     </li>",
"     <li>",
"      Glucose and hemoglobin A1C",
"     </li>",
"     <li>",
"      Renal and liver function tests",
"     </li>",
"     <li>",
"      Angiotensin converting enzyme",
"     </li>",
"     <li>",
"      Antinuclear antibody",
"     </li>",
"     <li>",
"      Anti-dsDNA antibody",
"     </li>",
"     <li>",
"      Anti-Sm antibody",
"     </li>",
"     <li>",
"      Antinuclear cytoplasmic antibody",
"     </li>",
"     <li>",
"      Fluorescent treponemal antibody test",
"     </li>",
"     <li>",
"      Lyme serologies",
"     </li>",
"     <li>",
"      Serum protein electrophoresis",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate (ESR)",
"     </li>",
"     <li>",
"      C reactive protein",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with Tolosa-Hunt syndrome, these results are generally normal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/10\">",
"     10",
"    </a>",
"    ]. Although case reports of elevated ESR, mild leukocytosis, and antinuclear antibody concentrations have been reported in Tolosa-Hunt syndrome, these should suggest an underlying connective tissue disorder.",
"   </p>",
"   <p>",
"    Cerebrospinal fluid should also be evaluated for protein, glucose, cell count with differential, cytology, Lyme and syphilis serology, angiotensin converting enzyme (for sarcoidosis), and cultures for bacteria, fungi, and mycobacteria. The expected findings in Tolosa-Hunt syndrome are normal. Mildly raised protein",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mild pleocytosis have been reported, but if found, these should suggest alternative diagnoses (neoplasm, inflammatory or infectious meningitis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Response to glucocorticoids and further investigation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoid administration has diagnostic as well as therapeutic utility. Rapid resolution of pain (within 24 to 72 hours) helps to confirm suspected Tolosa-Hunt syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/4,8\">",
"     4,8",
"    </a>",
"    ]. Improvement of cranial nerve deficits and regression of MRI abnormalities over the next two to eight weeks provide further confirmation of the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/10,26\">",
"     10,26",
"    </a>",
"    ]. However, an initial clinical or MRI response to steroids is not diagnostic; other entities, such as lymphoma and vasculitis, may also respond clinically and radiographically to glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinician needs to be vigilant regarding the continued possibility of misdiagnosis of Tolosa-Hunt syndrome (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Follow-up'",
"    </a>",
"    below). More aggressive testing, including repeat CSF evaluation and consideration of surgical biopsy, is recommended if symptoms do not respond promptly to steroids, or if glucocorticoid efficacy is lost after an initial response.",
"   </p>",
"   <p>",
"    Even with careful adherence to clinical criteria and diagnostic evaluation, misdiagnosis still occurs. As an example, a case of painful ophthalmoplegia with characteristic clinical and MRI findings, both initially glucocorticoid responsive, was subsequently demonstrated to be caused by actinomycosis infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/27\">",
"     27",
"    </a>",
"    ]. An underlying neoplasm was finally diagnosed in other patients who either failed to respond to initial glucocorticoid therapy or did not maintain a clinical response [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/10,28-30\">",
"     10,28-30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids have been the recommended treatment for Tolosa-Hunt syndrome since the 1960s [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. However, there are little data other than case series to determine the most effective dose, route and schedule of administration, or length of glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"     7",
"    </a>",
"    ]. While glucocorticoids clearly hasten the resolution of orbital pain, there is no definitive evidence that the cranial neuropathies recover any faster with or without treatment. Little consideration has been given to alternative therapies, probably due to the typical rapid response to glucocorticoids.",
"   </p>",
"   <p>",
"    Specific glucocorticoid regimens reported for treatment of Tolosa-Hunt syndrome vary, but in general they include initial high-dose glucocorticoids for two to four weeks followed by a gradual taper over the course of at least four to six weeks and up to several months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/10,31,32\">",
"     10,31,32",
"    </a>",
"    ]. Prompt administration of IV glucocorticoids is often recommended, but oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is also effective. The rate of the taper should be guided by clinical symptoms, but persistent magnetic resonance imaging (MRI) findings should not deter dose reductions as long as the findings are regressing.",
"   </p>",
"   <p>",
"    A suggested glucocorticoid regimen is:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       Prednisone",
"      </a>",
"      80 to 100 mg daily for three days.",
"     </li>",
"     <li>",
"      If the pain has resolved, taper to 60 mg daily, then 40 mg, then 20 mg, then 10 mg every two weeks.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Close clinical follow-up with repeat MRI is necessary to be sure the glucocorticoid treatment remains effective and no evidence of another etiology develops. Radiographic improvement often lags several weeks behind clinical improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. In uncomplicated patients, MRI scans to monitor improvement and maintenance of improvement on and then off treatment should be performed every one to two months until findings normalize [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/1\">",
"     1",
"    </a>",
"    ]. This should be followed by MRI scans every six months for a period of two years following the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/15\">",
"     15",
"    </a>",
"    ]. MRI and other diagnostic testing should be performed promptly if symptoms recur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Second-line treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small group of patients will require other immunosuppressive medications either to limit the complications of corticosteroid use or to keep the disorder in remission. Typically, such patients will have biopsy confirmation of the diagnosis.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    have been used in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/15,33-35\">",
"     15,33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A few case reports have described long-term remittance of symptoms with radiotherapy after a history of relapsing Tolosa-Hunt syndrome and corticosteroid dependence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/33,36\">",
"     33,36",
"    </a>",
"    ], or as primary treatment when corticosteroids are contraindicated [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids drastically hasten the resolution of symptoms, with pain resolving within 24 to 72 hours after initiating treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/4\">",
"     4",
"    </a>",
"    ]. Cranial neuropathies tend to recover more slowly over two to eight weeks even with glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/4,10,26,38\">",
"     4,10,26,38",
"    </a>",
"    ]. In unusual cases, residual deficits remain [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/3,7\">",
"     3,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recurrences occur in about one-half of reported patients over an interval of months to years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/3,7\">",
"     3,7",
"    </a>",
"    ]. Ipsilateral, contralateral, and bilateral relapses have been reported. Relapses require repeated investigations to rule out inflammatory and neoplastic disorders such as sarcoid, Wegener's granulomatosis, and lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24006/abstract/15,36\">",
"     15,36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Diagnostic evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    There is no evidence that corticosteroid therapy alters the prognosis with regard to the frequency of relapses or persistent ophthalmoplegia. It is unlikely that this information will be forthcoming given the relative rarity of the disorder and the widespread use of glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Tolosa-Hunt syndrome is caused by an inflammation in the cavernous sinus or superior orbital fissure of unknown etiology. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardinal features include retroorbital pain and ophthalmoplegia affecting the third, fourth,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      sixth cranial nerves. All age groups may be affected. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis includes malignancies and infections, as well as vascular and other inflammatory etiologies (",
"      <a class=\"graphic graphic_table graphicRef77825 \" href=\"UTD.htm?3/54/3949\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Contrast-enhanced magnetic resonance imaging (MRI), blood, and cerebrospinal fluid evaluation are required to exclude other conditions. Results of these tests, with a characteristic response to corticosteroid therapy, support but do not definitively confirm the diagnosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend treatment with glucocorticoids for those who meet clinical and diagnostic criteria for Tolosa-Hunt syndrome (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      80 to 100 mg daily for three days. If pain has resolved, we then taper prednisone to 60 mg, then to 40 mg, 20 mg, and 10 mg in two-week intervals. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Close clinical and MRI follow-up is essential. We recommend repeating diagnostic investigations and consideration of a surgical biopsy for patients who fail to respond clinically or radiographically to treatment, or who relapse on treatment. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Response to glucocorticoids and further investigation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis for most patients is favorable. However, some patients follow a relapsing-remitting course requiring prolonged corticosteroid or other immunosuppressive therapy, and a few have permanent cranial nerve deficits. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/1\">",
"      Iaconetta G, Stella L, Esposito M, Cappabianca P. Tolosa-Hunt syndrome extending in the cerebello-pontine angle. Cephalalgia 2005; 25:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/2\">",
"      TOLOSA E. Periarteritic lesions of the carotid siphon with the clinical features of a carotid infraclinoidal aneurysm. J Neurol Neurosurg Psychiatry 1954; 17:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/3\">",
"      HUNT WE, MEAGHER JN, LEFEVER HE, ZEMAN W. Painful opthalmoplegia. Its relation to indolent inflammation of the carvernous sinus. Neurology 1961; 11:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/4\">",
"      Smith JL, Taxdal DS. Painful ophthalmoplegia. The Tolosa-Hunt syndrome. Am J Ophthalmol 1966; 61:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/5\">",
"      Calistri V, Mostardini C, Pantano P, et al. Tolosa-Hunt syndrome in a patient with systemic lupus erythematosus. Eur Radiol 2002; 12:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/6\">",
"      Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004; 24 Suppl 1:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/7\">",
"      Kline LB, Hoyt WF. The Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry 2001; 71:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/8\">",
"      Colnaghi S, Versino M, Marchioni E, et al. ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus. Cephalalgia 2008; 28:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/9\">",
"      Tessitore E, Tessitore A. Tolosa-Hunt syndrome preceded by facial palsy. Headache 2000; 40:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/10\">",
"      Cakirer S. MRI findings in Tolosa-Hunt syndrome before and after systemic corticosteroid therapy. Eur J Radiol 2003; 45:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/11\">",
"      de Arcaya AA, Cerezal L, Canga A, et al. Neuroimaging diagnosis of Tolosa-Hunt syndrome: MRI contribution. Headache 1999; 39:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/12\">",
"      Sondheimer FK, Knapp J. Angiographic findings in the Tolosa-Hunt syndrome: painful ophthalmoplegia. Radiology 1973; 106:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/13\">",
"      Inzitari D, Sit&agrave; D, Marconi GP, Barontini F. The tolosa-Hunt syndrome: further clinical and pathogenetic considerations based on the study of eight cases. J Neurol 1981; 224:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/14\">",
"      Adams AH, Warner AM. Painful ophthalmoplegia: report of a case with cerebral involvement and psychiatric complications. Bull Los Angeles Neurol Soc 1975; 40:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/15\">",
"      F&ouml;rderreuther S, Straube A. The criteria of the International Headache Society for Tolosa-Hunt syndrome need to be revised. J Neurol 1999; 246:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/16\">",
"      Cakirer S. MRI findings in the patients with the presumptive clinical diagnosis of Tolosa-Hunt syndrome. Eur Radiol 2003; 13:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/17\">",
"      Keane JR. Cavernous sinus syndrome. Analysis of 151 cases. Arch Neurol 1996; 53:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/18\">",
"      Wasmeier C, Pfadenhauer K, R&ouml;sler A. Idiopathic inflammatory pseudotumor of the orbit and Tolosa-Hunt syndrome--are they the same disease? J Neurol 2002; 249:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/19\">",
"      Goto Y, Hosokawa S, Goto I, et al. Abnormality in the cavernous sinus in three patients with Tolosa-Hunt syndrome: MRI and CT findings. J Neurol Neurosurg Psychiatry 1990; 53:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/20\">",
"      Zournas C, Trakadas S, Kapaki E, et al. Gadopentetate dimeglumine-enhanced MR in the diagnosis of the Tolosa-Hunt syndrome. AJNR Am J Neuroradiol 1995; 16:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/21\">",
"      Pascual J, Cerezal L, Canga A, et al. Tolosa-Hunt syndrome: focus on MRI diagnosis. Cephalalgia 1999; 19 Suppl 25:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/22\">",
"      Schuknecht B, Sturm V, Huisman TA, Landau K. Tolosa-Hunt syndrome: MR imaging features in 15 patients with 20 episodes of painful ophthalmoplegia. Eur J Radiol 2009; 69:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/23\">",
"      K&oacute;bor J, V&ouml;r&ouml;s E, De&aacute;k A. Magnetic resonance imaging in Tolosa-Hunt syndrome. Eur J Pediatr 2004; 163:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/24\">",
"      Kwan ES, Wolpert SM, Hedges TR 3rd, Laucella M. Tolosa-Hunt syndrome revisited: not necessarily a diagnosis of exclusion. AJR Am J Roentgenol 1988; 150:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/25\">",
"      Yousem DM, Atlas SW, Grossman RI, et al. MR imaging of Tolosa-Hunt syndrome. AJR Am J Roentgenol 1990; 154:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/26\">",
"      Yeh YF, Hsieh FY, Chen ST, Ng SH. Magnetic resonance images of Tolosa-Hunt syndrome before and after steroid therapy. J Formos Med Assoc 1996; 95:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/27\">",
"      Mandrioli J, Frank G, Sola P, et al. Tolosa-Hunt syndrome due to actinomycosis of the cavernous sinus: the infectious hypothesis revisited. Headache 2004; 44:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/28\">",
"      Leijzer CT, Prevo RL, Hageman G. Meningioma presenting as Tolosa-Hunt syndrome. Clin Neurol Neurosurg 1999; 101:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/29\">",
"      Esmaeli B, Ginsberg L, Goepfert H, Deavers M. Squamous cell carcinoma with perineural invasion presenting as a Tolosa-Hunt-like syndrome: a potential pitfall in diagnosis. Ophthal Plast Reconstr Surg 2000; 16:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/30\">",
"      Sedwick LA, Kaufman DI, Fratkin J. Really painful double vision. Surv Ophthalmol 2000; 45:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/31\">",
"      Haque TL, Miki Y, Kashii S, et al. Dynamic MR imaging in Tolosa-Hunt syndrome. Eur J Radiol 2004; 51:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/32\">",
"      Sugano H, Iizuka Y, Arai H, Sato K. Progression of Tolosa-Hunt syndrome to a cavernous dural arteriovenous fistula: a case report. Headache 2003; 43:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/33\">",
"      Mormont E, Laloux P, Vauthier J, Ossemann M. Radiotherapy in a case of Tolosa-Hunt syndrome. Cephalalgia 2000; 20:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/34\">",
"      Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001; 85:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/35\">",
"      O' Connor G, Hutchinson M. Tolosa-Hunt syndrome responsive to infliximab therapy. J Neurol 2009; 256:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/36\">",
"      Foubert-Samier A, Sibon I, Maire JP, Tison F. Long-term cure of Tolosa-Hunt syndrome after low-dose focal radiotherapy. Headache 2005; 45:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/37\">",
"      Furukawa Y, Yamaguchi W, Ito K, et al. The efficacy of radiation monotherapy for Tolosa-Hunt syndrome. J Neurol 2010; 257:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24006/abstract/38\">",
"      Neigel JM, Rootman J, Robinson RG, et al. The Tolosa-Hunt syndrome: computed tomographic changes and reversal after steroid therapy. Can J Ophthalmol 1986; 21:287.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5248 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-41275854C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24006=[""].join("\n");
var outline_f23_28_24006=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Blood and CSF evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Response to glucocorticoids and further investigation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Follow-up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Second-line treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5248\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5248|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/54/3949\" title=\"table 1\">",
"      Causes of painful ophthalmoplegia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=related_link\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/8/20616?source=related_link\">",
"      Neurologic sarcoidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_28_24007="Pathogenesis and causes of hirsutism";
var content_f23_28_24007=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and causes of hirsutism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/28/24007/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24007/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24007/contributors\">",
"     David A Ehrmann, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/28/24007/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24007/contributors\">",
"     Peter J Snyder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24007/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/28/24007/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/28/24007/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/28/24007/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hirsutism, defined as excessive male-pattern hair growth, affects between 5 and 10 percent of women of reproductive age. Hirsutism may be the initial and possibly only sign of androgen excess, the cutaneous manifestations of which may also include acne and male-pattern balding (androgenic alopecia). The pathophysiology and causes of androgen-mediated hair growth are reviewed here. Evaluation and treatment of hirsutism are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link\">",
"     \"Evaluation of premenopausal women with hirsutism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HAIR GROWTH CYCLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Humans are born with approximately five million hair follicles and it is estimated that 80,000 to 150,000 of them are located on the scalp. Hair can be categorized as either vellus (fine, soft, and not pigmented) or terminal (long, coarse, and pigmented) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/1\">",
"     1",
"    </a>",
"    ]. The number of hair follicles does not change over an individual's lifetime, but the follicle size and type of hair can change in response to numerous factors, particularly androgens.",
"   </p>",
"   <p>",
"    The hair growth cycle is comprised of three phases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The growth phase (termed anagen), which lasts two to three years.",
"     </li>",
"     <li>",
"      The involutional phase (catagen), which lasts two to three weeks.",
"     </li>",
"     <li>",
"      The resting phase (telogen), which lasts three to four months. Hair is released from the hair shaft and shed at the end of telogen, and the next cycle is initiated. Telogen hairs are characterized by a mature root sheath or \"club\" at the proximal end.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Depending upon the body site, hormonal regulation plays an important role in the hair growth cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/1\">",
"     1",
"    </a>",
"    ]. Androgens increase hair follicle size, hair fiber diameter, and the proportion of time terminal hairs spend in the anagen phase [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/3\">",
"     3",
"    </a>",
"    ]. Androgen excess in women leads to increased hair growth in most androgen sensitive sites (eg, upper lip, chin, midsternum, upper abdomen, back, and buttocks), but to loss of hair in the scalp region, in part by reducing the time scalp hairs spend in anagen phase.",
"   </p>",
"   <p>",
"    Androgens are necessary for terminal hair and sebaceous gland development and cause differentiation of pilosebaceous units (PSUs) into either a terminal hair follicle or a sebaceous gland (",
"    <a class=\"graphic graphic_figure graphicRef52814 \" href=\"UTD.htm?15/0/15362\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/1\">",
"     1",
"    </a>",
"    ]. In the former case, androgens transform the vellus hair into a terminal hair (a large medullated hair); in the latter, the sebaceous component proliferates and the hair remains vellus. In androgen-sensitive areas before puberty, the hair is vellus and the sebaceous glands are small. In response to increasing levels of androgens, PSUs become large terminal hair follicles in sexual hair areas or they become sebaceous follicles (sebaceous glands) in sebaceous areas. Androgens promote growth of sexual hair by recruiting a population of PSUs to switch from producing vellus hairs to initiating terminal hair growth.",
"   </p>",
"   <p>",
"    Male-pattern hair growth occurs in sites where relatively high levels of androgen are necessary for pilosebaceous unit differentiation. Although androgen excess underlies most cases of hirsutism, there is only a modest correlation between the quantity of hair growth and androgen levels [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/4\">",
"     4",
"    </a>",
"    ]. This is thought to result from the fact that stimulation of hair growth from the follicle does not depend solely on circulating androgen concentrations, but also depends upon local factors and variability in end-organ sensitivity to circulating androgens [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excess androgen secretion in women is referred to as hyperandrogenemia, which can manifest as hyperandrogenism: hirsutism, acne, androgenic alopecia, and virilization. Hirsutism, defined as excessive growth of terminal hair in women in a male-like pattern, is the most commonly used clinical diagnostic criterion of hyperandrogenism [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Virilization, which is rare, occurs only with severe hyperandrogenism, and includes deepening of the voice and clitoromegaly.",
"   </p>",
"   <p>",
"    A commonly used method to grade hair growth is a modified scale of Ferriman and Gallwey [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/5\">",
"     5",
"    </a>",
"    ]. Approximately 95 percent of women have a Ferriman-Gallwey score of less than 8. However, there are a number of limitations of the Ferriman-Gallwey score, including the variability in expression of hair growth between",
"    <span class=\"nowrap\">",
"     racial/ethnic",
"    </span>",
"    groups. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Ethnicity'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation of premenopausal women with hirsutism\", section on 'Ferriman-Gallwey score'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nearly all hirsute women have an increased production rate of androgens, usually testosterone, but the increase may not be sufficient to raise the serum total testosterone concentration above the normal range because the carrier protein for testosterone, sex hormone binding globulin, is suppressed when androgen production is increased [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. The resulting decrease in SHBG allows its clearance to increase, therefore leading to decreased serum concentrations of androgens. In other women, hirsutism may be due to increased conversion of testosterone to dihydrotestosterone by the enzyme 5 alpha reductase within the pilosebaceous unit in peripheral tissue, including hair follicles [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are two conditions characterized by generalized hair growth that do not represent true hirsutism:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Androgen-independent hair, which is the soft vellus unpigmented hair that covers the entire body. In infants, this hair is called lanugo.",
"     </li>",
"     <li>",
"      Hypertrichosis, which refers to diffusely increased total body hair growth. This is a rare condition that is usually caused by a drug, examples of which include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"       penicillamine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/38/13924?source=see_link\">",
"       diazoxide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/5/32848?source=see_link\">",
"       minoxidil",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      . Hypertrichosis also can occur in patients with some systemic illnesses, such as hypothyroidism, anorexia nervosa, malnutrition, porphyria, and dermatomyositis, and as a paraneoplastic syndrome in some patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=see_link&amp;anchor=H26#H26\">",
"       \"Cutaneous manifestations of internal malignancy\", section on 'Hypertrichosis lanuginosa'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hirsutism may affect between 5 and 10 percent of women of reproductive age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/5,12\">",
"     5,12",
"    </a>",
"    ]; most women with hirsutism have polycystic ovary syndrome (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Polycystic ovary syndrome'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    In a classic study of 430 British women aged 15 to 64 years attending a general medical clinic, 49 percent had hair on the lip, 22 percent had hair on the chin, 10 percent had hair on the chest, and no woman had terminal hair on the upper back or upper abdomen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/5\">",
"     5",
"    </a>",
"    ]. In most of the women who had hair in any region, however, there were rarely more than a few scattered hairs; thus, graded on a scale of 0 to 4 at nine sites (modified Ferriman-Gallwey scoring system), only 1.2 percent of women aged 18 to 38 years had scores above 10. However, in a separate study, most women with a score above 3 considered themselves to be hirsute [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation of premenopausal women with hirsutism\", section on 'Ferriman-Gallwey score'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Ethnicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definition of normal must also consider race and ethnicity. Most Asian and Native American women have little body hair, while Mediterranean women on average have substantially greater quantities of body hair even though serum androgen concentrations are similar in the three groups [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/14\">",
"     14",
"    </a>",
"    ]. These differences must be kept in mind in determining whether a woman has a pathologic degree of hirsutism and whether she should be evaluated further. Thus, an Asian woman with a few peri-areolar hairs may warrant further evaluation, whereas a Mediterranean woman with some hair growth on her upper lip might well be considered normal, and consider herself normal. However, further evaluation may still be indicated in such women. The most important consideration, whatever the woman's background, is whether the pattern of hair growth has changed or the rate of growth has increased. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation of premenopausal women with hirsutism\", section on 'Ferriman-Gallwey score'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hirsutism is a result of the interaction between circulating serum androgens and the sensitivity of the hair follicle to androgens. Several different androgens may be secreted in excess (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/12?source=see_link\">",
"     \"Steroid hormone metabolism in polycystic ovary syndrome\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testosterone, which is usually of ovarian origin",
"     </li>",
"     <li>",
"      Dehydroepiandrosterone sulfate (DHEA-S), which is of adrenal origin",
"     </li>",
"     <li>",
"      Androstenedione, which can be of either adrenal or ovarian origin",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although DHEA and DHEA-S are general markers of adrenal androgen production, they have little intrinsic androgenic activity. Small amounts are converted to androstenedione and then to testosterone (and to estrone and estradiol) in both the adrenal glands and peripheral tissues, including hair follicles and external genitalia. Thus, the hirsutism and virilization that may be seen with adrenal hyperandrogenism are caused by androstenedione and testosterone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=see_link\">",
"     \"Adrenal hyperandrogenism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Polycystic ovary syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polycystic ovary syndrome (PCOS) is the most common cause of hirsutism in women (",
"    <a class=\"graphic graphic_table graphicRef65205 \" href=\"UTD.htm?25/33/26139\">",
"     table 1",
"    </a>",
"    ). The syndrome is characterized by menstrual irregularity and hyperandrogenism, both clinical (hirsutism, acne, or male pattern balding) and biochemical (elevated serum androgen concentrations). The diagnostic criteria, clinical manifestations, and treatment of PCOS are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link\">",
"     \"Clinical manifestations of polycystic ovary syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=see_link\">",
"     \"Diagnosis of polycystic ovary syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1817?source=see_link\">",
"     \"Treatment of polycystic ovary syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study prospectively evaluated 350 British women: 319 with hirsutism and 31 with frontal balding [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/15\">",
"     15",
"    </a>",
"    ]. Among the 282 women who had ovarian ultrasonography, 170 (60 percent) had polycystic ovaries; one-half of these women also had menstrual irregularity and, therefore, met the original criteria for the polycystic ovary syndrome. The remainder would have originally been considered to have idiopathic hirsutism, but could perhaps now be considered to have PCOS using the newer Rotterdam PCOS diagnostic criteria. Only 2.3 percent (eight patients) had an identifiable endocrine disorder other than the polycystic ovary syndrome (congenital adrenal hyperplasia, ovarian tumor, virilizing adrenal carcinoma, prolactinoma, acromegaly).",
"   </p>",
"   <p>",
"    In two other series of 873 and 950 women presenting with androgen excess symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/16,17\">",
"     16,17",
"    </a>",
"    ], PCOS was diagnosed (using the original criteria of oligomenorrhea and hyperandrogenism) in 82 and 57 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=see_link\">",
"     \"Diagnosis of polycystic ovary syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The androgen excess in women with the polycystic ovary syndrome usually becomes evident about the time of puberty or soon thereafter, because androgen production is increased by both puberty (increased ovarian steroid production) and adrenarche (increased adrenal androgen production). Other diagnoses such as ovarian or adrenal tumors should be considered in older women, particularly those who have rapid development of hirsutism",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other signs of hyperandrogenism or even virilization or have a sudden onset of menstrual irregularity.",
"   </p>",
"   <p>",
"    The evaluation of hirsutism is complicated by the lack of reliable androgen assays and robust normative data in women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link&amp;anchor=H600539558#H600539558\">",
"     \"Evaluation of premenopausal women with hirsutism\", section on 'Testosterone'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Idiopathic hirsutism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of idiopathic hirsutism is given to women with hirsutism but normal serum androgen concentrations, no menstrual irregularity, and no identifiable cause of the hirsutism [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/4,18,19\">",
"     4,18,19",
"    </a>",
"    ]. In some women, there may be a steroidogenic abnormality despite the apparently normal serum androgen levels [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/20\">",
"     20",
"    </a>",
"    ]. The distinction between idiopathic disease and the polycystic ovary syndrome may be one of degree. As noted, many women who were previously considered to have idiopathic hirsutism would now be considered to have PCOS if using the newer Rotterdam PCOS diagnostic criteria. This is because most would meet two criteria for PCOS: clinical hyperandrogenism (hirsutism) and polycystic ovaries on ultrasound, which has been reported in over 90 percent of women with &ldquo;idiopathic hirsutism&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=see_link\">",
"     \"Diagnosis of polycystic ovary syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Congenital adrenal hyperplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excess androgen production is a key feature of most forms of congenital adrenal hyperplasia. These disorders are usually recognized at birth or in early infancy, but nonclassic (also called late-onset) forms of several of them have been identified. Affected women present peripubertally with hirsutism and sometimes menstrual irregularity or primary amenorrhea; they have no manifestations of cortisol deficiency. The prevalence of nonclassic congenital adrenal hyperplasia among hirsute women has varied from 1 to 15 percent in different studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. It is nearly always due to 21-hydroxylase (P450c21) deficiency, which leads to increased production of both 17-hydroxyprogesterone (the substrate for 21-hydroxylase and an androgen precursor) and androstenedione (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"     figure 2",
"    </a>",
"    ). (In nonclassic adrenal hyperplasia, cortisol production is not decreased due to an increase in ACTH secretion.) (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=see_link\">",
"     \"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28391?source=see_link\">",
"     \"Adrenal steroid biosynthesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Ovarian tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hirsutism caused by an androgen-secreting tumor is most likely to occur later in life and progress more rapidly than when the cause is the polycystic ovary syndrome. Androgen-secreting tumors constitute only 5 percent of all ovarian tumors; histologically they are Sertoli-Leydig cell tumors (androblastoma, arrhenoblastoma), granulosa-theca cell (stromal cell) tumors, and hilus-cell tumors. Most of the women have serum testosterone concentrations greater than 150 to 200",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (5.2 to 6.9",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. (The upper limit of normal for serum testosterone in women varies from 60 to 80",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    [2.1 to 2.8",
"    <span class=\"nowrap\">",
"     nmol/L]",
"    </span>",
"    in most laboratories.) Many of these tumors can be identified by transvaginal ultrasonography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/22/12646?source=see_link&amp;anchor=H11#H11\">",
"     \"Sex cord-stromal tumors of the ovary: Sertoli-stromal cell tumors\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32916?source=see_link&amp;anchor=H1#H1\">",
"     \"Sex cord-stromal tumors of the ovary: Tumors with granulosa and Sertoli-Leydig elements\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Adrenal tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal tumors are a rare cause of androgen excess. A few are adrenal adenomas that secrete mostly testosterone, but most are carcinomas that often secrete not only androgen (mostly DHEA and DHEA-S), but also cortisol; therefore, the woman may have clinical manifestations of androgen excess and Cushing's syndrome. Some of the carcinomas may lose the ability to sulfate DHEA, so a normal serum DHEA-S value does not exclude the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/28/24007/abstract/29\">",
"     29",
"    </a>",
"    ]. Nevertheless, an unequivocally elevated serum DHEA-S value is suggestive of an adrenal carcinoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=see_link\">",
"     \"Clinical presentation and evaluation of adrenocortical tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H678921\">",
"    <span class=\"h2\">",
"     Cushing&rsquo;s disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal overactivity due to a corticotroph adenoma secreting ACTH excessively results not only in excessive secretion of cortisol but also of adrenal androgens, typically resulting in hirsutism. Although the majority of women who have Cushing&rsquo;s disease have hirsutism, only a very small fraction of women with hirsutism have Cushing&rsquo;s disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology and clinical manifestations of Cushing's syndrome\", section on 'Signs of adrenal androgen excess'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hyperthecosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthecosis is a nonmalignant ovarian disorder characterized by increased production of testosterone by luteinized thecal cells in the stroma, leading to markedly increased serum testosterone concentrations. It is still unclear if hyperthecosis is a distinct disorder or is part of the spectrum of the polycystic ovary syndrome. The woman's history usually is one of gradual onset of hirsutism and frank virilization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38662?source=see_link\">",
"     \"Ovarian hyperthecosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Severe insulin resistance syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who have one of the syndromes of severe insulin resistance and marked hyperinsulinemia often have hirsutism. The marked hyperinsulinemia causes ovarian hyperandrogenism, possibly acting via the theca-cell receptors for insulin and insulin-like growth factor-1 (",
"    <a class=\"graphic graphic_figure graphicRef61896 \" href=\"UTD.htm?38/60/39886\">",
"     figure 3",
"    </a>",
"    ). Insulin also decreases serum sex hormone-binding globulin concentrations, thereby increasing the fraction of serum testosterone that is free at any serum total testosterone concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=see_link&amp;anchor=H9#H9\">",
"     \"Insulin resistance: Definition and clinical spectrum\", section on 'Hyperandrogenism and reproductive abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The syndromes of severe insulin resistance include genetic defects in the insulin receptor, the production of antibodies to the insulin receptor, and several syndromes of lipoatrophy and lipodystrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=see_link\">",
"     \"Insulin resistance: Definition and clinical spectrum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen therapy (testosterone or DHEA) may be associated with hirsutism.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     Danazol",
"    </a>",
"    , a drug commonly used in the past for the treatment of endometriosis, is also associated with hirsutism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/45/20184?source=see_link\">",
"     \"Androgen production and therapy in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/56/9090?source=see_link\">",
"       \"Patient information: Hirsutism (excess hair growth in women) (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/61/28626?source=see_link\">",
"       \"Patient information: Sertoli-Leydig cell tumor (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/24/13698?source=see_link\">",
"       \"Patient information: Hirsutism (excess hair growth in women) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hirsutism, defined as excessive male-pattern hair growth, affects between 5 and 10 percent of women of reproductive age. It may be the initial and possibly only sign of an underlying androgen disorder, the cutaneous manifestations of which may also include acne and male-pattern balding (androgenetic alopecia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23336?source=see_link\">",
"     \"Treatment of androgenetic alopecia in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Depending upon the body site, hormonal regulation plays an important role in the hair growth cycle. Androgens increase hair follicle size, hair fiber diameter, and the proportion of time terminal hairs spend in the anagen phase. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Hair growth cycle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Race and ethnicity are important determinants of body hair distribution in women. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Ethnicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Polycystic ovary syndrome is the most common cause of hirsutism. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Polycystic ovary syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of idiopathic hirsutism is given to women with hirsutism with normal serum androgen concentrations, no menstrual irregularity, and no identifiable cause of their hirsutism. However, if using the Rotterdam criteria for PCOS diagnosis, many women with idiopathic hirsutism would be considered to have a subtle form of PCOS. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Idiopathic hirsutism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of hirsutism include congenital adrenal hyperplasia, ovarian and adrenal androgen-secreting tumors, medications, and other rare disorders. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/1\">",
"      Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/2\">",
"      Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999; 341:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/3\">",
"      Messenger AG. The control of hair growth: an overview. J Invest Dermatol 1993; 101:4S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/4\">",
"      Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000; 21:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/5\">",
"      FERRIMAN D, GALLWEY JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/6\">",
"      Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med 2005; 353:2578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/7\">",
"      Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/8\">",
"      Samojlik E, Kirschner MA, Silber D, et al. Elevated production and metabolic clearance rates of androgens in morbidly obese women. J Clin Endocrinol Metab 1984; 59:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/9\">",
"      Kirschner MA, Samojlik E, Silber D. A comparison of androgen production and clearance in hirsute and obese women. J Steroid Biochem 1983; 19:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/10\">",
"      Matteri RK, Stanczyk FZ, Gentzschein EE, et al. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome. Am J Obstet Gynecol 1989; 161:1704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/11\">",
"      Labrie F. Intracrinology. Mol Cell Endocrinol 1991; 78:C113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/12\">",
"      Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83:3078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/13\">",
"      DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 2006; 91:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/14\">",
"      Carmina E, Koyama T, Chang L, et al. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992; 167:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/15\">",
"      O'Driscoll JB, Mamtora H, Higginson J, et al. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 1994; 41:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/16\">",
"      Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/17\">",
"      Carmina E, Rosato F, Jann&igrave; A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006; 91:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/18\">",
"      Moore A, Magee F, Cunningham S, et al. Adrenal abnormalities in idiopathic hirsutism. Clin Endocrinol (Oxf) 1983; 18:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/19\">",
"      Glickman SP, Rosenfield RL. Androgen metabolism by isolated hairs from women with idiopathic hirsutism is usually normal. J Invest Dermatol 1984; 82:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/20\">",
"      Escobar-Morreale HF, Serrano-Gotarredona J, Garc&iacute;a-Robles R, et al. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metabolism 1997; 46:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/21\">",
"      Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986; 293:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/22\">",
"      Chetkowski RJ, DeFazio J, Shamonki I, et al. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab 1984; 58:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/23\">",
"      Kuttenn F, Couillin P, Girard F, et al. Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 1985; 313:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/24\">",
"      Hawkins LA, Chasalow FI, Blethen SL. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea. J Clin Endocrinol Metab 1992; 74:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/25\">",
"      Dewailly D, Vantyghem MC, Lemaire C, et al. Screening heterozygotes for 21-hydroxylase deficiency among hirsute women: lack of utility of the adrenocorticotropin hormone test. Fertil Steril 1988; 50:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/26\">",
"      Moltz L, Pickartz H, S&ouml;rensen R, et al. Ovarian and adrenal vein steroids in seven patients with androgen-secreting ovarian neoplasms: selective catheterization findings. Fertil Steril 1984; 42:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/27\">",
"      Friedman CI, Schmidt GE, Kim MH, Powell J. Serum testosterone concentrations in the evaluation of androgen-producing tumors. Am J Obstet Gynecol 1985; 153:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/28\">",
"      Meldrum DR, Abraham GE. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors. Obstet Gynecol 1979; 53:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/28/24007/abstract/29\">",
"      Derksen J, Nagesser SK, Meinders AE, et al. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994; 331:968.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7439 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24007=[""].join("\n");
var outline_f23_28_24007=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HAIR GROWTH CYCLE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Ethnicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Idiopathic hirsutism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Congenital adrenal hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Ovarian tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Adrenal tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H678921\">",
"      Cushing&rsquo;s disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hyperthecosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Severe insulin resistance syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7439\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7439|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/0/15362\" title=\"figure 1\">",
"      Androgens in the development of the pilosebaceous unit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/7/123\" title=\"figure 2\">",
"      Adrenal steroid synthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/60/39886\" title=\"figure 3\">",
"      IGF receptors in insulin resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7439|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/33/26139\" title=\"table 1\">",
"      Causes of hirsutism in women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=related_link\">",
"      Adrenal hyperandrogenism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28391?source=related_link\">",
"      Adrenal steroid biosynthesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/45/20184?source=related_link\">",
"      Androgen production and therapy in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=related_link\">",
"      Clinical manifestations of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=related_link\">",
"      Clinical presentation and evaluation of adrenocortical tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=related_link\">",
"      Cutaneous manifestations of internal malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=related_link\">",
"      Diagnosis of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=related_link\">",
"      Epidemiology and clinical manifestations of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=related_link\">",
"      Evaluation of premenopausal women with hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=related_link\">",
"      Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=related_link\">",
"      Insulin resistance: Definition and clinical spectrum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38662?source=related_link\">",
"      Ovarian hyperthecosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/24/13698?source=related_link\">",
"      Patient information: Hirsutism (excess hair growth in women) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/56/9090?source=related_link\">",
"      Patient information: Hirsutism (excess hair growth in women) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/61/28626?source=related_link\">",
"      Patient information: Sertoli-Leydig cell tumor (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/22/12646?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Sertoli-stromal cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32916?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Tumors with granulosa and Sertoli-Leydig elements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/12?source=related_link\">",
"      Steroid hormone metabolism in polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23336?source=related_link\">",
"      Treatment of androgenetic alopecia in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=related_link\">",
"      Treatment of hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1817?source=related_link\">",
"      Treatment of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_28_24008="Zidovudine: Drug information";
var content_f23_28_24008=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Zidovudine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?22/25/22933?source=see_link\">",
"    see \"Zidovudine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/55/27512?source=see_link\">",
"    see \"Zidovudine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F235151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Retrovir&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F235152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Zidovudine&reg;;",
"     </li>",
"     <li>",
"      AZT&trade;;",
"     </li>",
"     <li>",
"      Novo-AZT;",
"     </li>",
"     <li>",
"      Retrovir&reg;;",
"     </li>",
"     <li>",
"      Retrovir&reg; (AZT&trade;)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F235202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiretroviral Agent, Reverse Transcriptase Inhibitor (Nucleoside)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F235156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients should receive I.V. therapy only until oral therapy can be administered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention of maternal-fetal HIV transmission:",
"     </b>",
"     Dose adjustment not required in pregnant women. Begin oral therapy with usual recommended dose based on current treatment guidelines. Zidovudine should be administered by continuous I.V. infusion near delivery regardless of antepartum regimen or mode of delivery in women with HIV RNA &gt;400 copies/mL or unknown HIV RNA status. If oral zidovudine was part of the antepartum regimen, discontinue during intrapartum I.V. infusion. Other antiretroviral agents should be continued orally. Zidovudine I.V. is not required in women receiving combination antiretroviral therapy who have HIV RNA &lt;400 copies/mL near delivery (DHHS [perinatal], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     During labor and delivery, administer zidovudine I.V. at 2 mg/kg as loading dose followed by a continuous I.V. infusion of 1 mg/kg/hour until delivery. For scheduled cesarean delivery, begin I.V. zidovudine 3 hours before surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      HIV infection:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 300 mg twice daily or 200 mg 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     U.S. labeling: 1 mg/kg/dose administered every 4 hours around-the-clock (5-6 doses/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Canadian labeling: 1-2 mg/kg/dose administered every 4 hours around-the-clock (6 doses/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Postexposure prophylaxis (unlabeled use):",
"     </b>",
"     Oral: 300 mg twice daily or 200 mg 3 times daily in combination with lamivudine or emtricitabine. A third agent may be added for high risk exposures. Therapy should be started within hours of exposure and continued for 4 weeks (CDC, 2005).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F235179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/55/27512?source=see_link\">",
"      see \"Zidovudine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients should receive I.V. therapy only until oral therapy can be administered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention of maternal-fetal HIV transmission (in neonates):",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Start as soon as possible after birth, preferably within 6-12 hours of delivery. Continue dose from birth through 6 weeks of age. Use zidovudine in combination with nevirapine in select situations (eg, infants born to mothers with only intrapartum therapy or no therapy) (DHHS [perinatal], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Oral:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Manufacturer's labeling: Full-term infants: 2 mg/kg every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     DHHS [perinatal], 2012:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants &ge;35 weeks: 4 mg/kg/dose twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants &ge;30 weeks and &lt;35 weeks gestation at birth: 2 mg/kg/dose every 12 hours; at 15 days of age, advance to 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants &lt;30 weeks gestation at birth: 2 mg/kg/dose every 12 hours; at 4 weeks of age, advance to 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. (infants unable to receive oral dosing):",
"     </i>",
"     Start as soon as possible after birth, preferably within 6-12 hours of delivery; continue dose from birth through 6 weeks of age: DHHS [perinatal], 2012:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants &ge;35 weeks: 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants &ge;30 weeks and &lt;35 weeks gestation at birth: 1.5 mg/kg/dose every 12 hours; at 15 days of age, advance to 2.3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants &lt;30 weeks gestation at birth: 1.5 mg/kg/dose every 12 hours; at 4 weeks of age, advance to 2.3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of HIV infection:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 4 weeks to &lt;18 years (U.S. labeling) or 3 months to &le;12 years (Canadian labeling):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: Dose should be calculated by body weight (in kg) or body surface area and should not exceed the recommended adult dose.",
"     <b>",
"      Note:",
"     </b>",
"     Doses calculated by body weight may not be the same as those calculated by body surface area.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <i>",
"      Dosing based on body surface area:",
"     </i>",
"     240 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     twice daily (maximum: 300 mg twice daily)",
"     <b>",
"      or",
"     </b>",
"     160 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times daily (maximum: 200 mg 3 times daily)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <i>",
"      Dosing based on weight",
"     </i>",
"     (",
"     <b>",
"      Note:",
"     </b>",
"     3 times daily dose is approved but rarely used in clinical practice):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     4 to &lt;9 kg: 12 mg/kg/dose twice daily",
"     <b>",
"      or",
"     </b>",
"     8 mg/kg/dose 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &ge;9 to &lt;30 kg: 9 mg/kg/dose twice daily",
"     <b>",
"      or",
"     </b>",
"     6 mg/kg/dose 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &ge;30 kg: 300 mg twice daily",
"     <b>",
"      or",
"     </b>",
"     200 mg 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 3 months to &le;12 years (Canadian labeling):",
"     <i>",
"      I.V. intermittent infusion:",
"     </i>",
"     120 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years:",
"     <i>",
"      I.V. intermittent infusion:",
"     </i>",
"     1 mg/kg/dose every 4 hours around-the-clock",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F235157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F235158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute including hemo-/peritoneal dialysis (administer dose after dialysis on dialysis days [DHHS, 2012]):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Oral: 100 mg every 6-8 hours (manufacturers labeling); 100 mg 3 times daily",
"     <b>",
"      or",
"     </b>",
"     300 mg once daily (DHHS [adult], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     I.V.: 1 mg/kg every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): No adjustment needed (Aronoff, 2007)",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F235159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Insufficient data to make dosing recommendation. The risk of hematologic toxicity may be increased.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F3011337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Consider dose interruption for significant anemia (hemoglobin &lt;7.5 g/dL or &gt;25% reduction from baseline) and/or neutropenia (granulocyte count &lt;750 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or &gt;50% reduction from baseline) until evidence of recovery. Anemia associated with chronic zidovudine may warrant dose reduction.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F235125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 100 mg [contains soya lecithin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 10 mg/mL (20 mL) [contains natural rubber/natural latex in packaging]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral: 10 mg/mL (240 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 10 mg/mL (240 mL) [contains sodium benzoate; strawberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 300 mg [DSC]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F235110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Capsule, syrup, tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F235128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer around-the-clock to promote less variation in peak and trough serum levels; may be administered without regard to meals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Do not administer I.M.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Avoid rapid infusion or bolus injection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neonates: Infuse over 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: Infuse over 1 hour; in pregnant women, infuse loading dose over 1 hour followed by continuous infusion",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F235209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Incompatible",
"     </b>",
"     with blood products and protein solutions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, allopurinol, amifostine, amikacin, amphotericin B, amphotericin B cholesteryl sulfate complex, anidulafungin, aztreonam, cefepime, ceftazidime, cimetidine, cisatracurium, clindamycin, dexamethasone sodium phosphate, dobutamine, docetaxel, dopamine, doripenem, doxorubicin liposome, erythromycin lactobionate, etoposide phosphate, filgrastim, fluconazole, fludarabine, gemcitabine, gentamicin, granisetron, heparin, imipenem/cilastatin, linezolid, lorazepam, melphalan, metoclopramide, morphine, nafcillin, ondansetron, oxacillin, oxytocin, paclitaxel, pantoprazole, pemetrexed, pentamidine, phenylephrine, piperacillin, piperacillin/tazobactam, potassium chloride, ranitidine, remifentanil, sargramostim, teniposide, thiotepa, tobramycin, trimethoprim/sulfamethoxazole, vancomycin, vinorelbine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftriaxone, meropenem.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Pantoprazole.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F235126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of HIV infection in combination with at least two other antiretroviral agents; prevention of maternal/fetal HIV transmission",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F235198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Postexposure prophylaxis for HIV exposure as part of a multidrug regimen",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F235211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Azidothymidine may be confused with azaTHIOprine, aztreonam",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Retrovir&reg; may be confused with acyclovir, ritonavir",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       AZT is an error-prone abbreviation (mistaken as azathioprine, aztreonam)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F235200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Percentages noted with adults unless otherwise stated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (63%), malaise (53%), fever (children 25%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (children 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (adults 51%; children 8%), anorexia (20%), vomiting (adults 17%; children 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Macrocytosis (children &gt;50%), anemia (neonates 22%; children 4%; adults 1%; onset 2-4 weeks)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Hepatomegaly (children 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough (children 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: ECG abnormality (children &lt;6%), edema (children &lt;6%), heart failure (children &lt;6%), left ventricular dilation (children &lt;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Irritability (children &lt;6%), nervousness (children &lt;6%), chills (&ge;5%), fatigue (&ge;5%), insomnia (&ge;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (children 8%), constipation (6%), weight loss (children &lt;6%), abdominal cramps (&ge;5%), abdominal pain (&ge;5%), dyspepsia (&ge;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Hematuria (children &lt;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Neutropenia (children 8%), granulocytopenia (2%; onset 6-8 weeks), thrombocytopenia (children 1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Transaminases increased (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (9%), arthralgia (&ge;5%), musculoskeletal pain (&ge;5%), myalgia (&ge;5%), neuropathy (&ge;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Discharge/erythema/pain/swelling (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Postmarketing and/or case reports: Allergic reactions, amblyopia, anaphylaxis, angioedema, anxiety, aplastic anemia, back pain, body fat redistribution, cardiomyopathy, confusion, CPK increased, depression, diabetes, dizziness, dyslipidemias, dyspnea, gynecomastia, hearing loss, hemolytic anemia, hepatitis, hepatomegaly with steatosis, immune reconstitution syndrome, insulin resistance, jaundice, lactic acidosis, LDH increased, leukopenia, loss of mental acuity, lymphadenopathy, macular edema, mania, myopathy, myositis, oral mucosa pigmentation, pancreatitis, pancytopenia with marrow hypoplasia, paresthesia, photophobia, pruritus, pure red cell aplasia, rhabdomyolysis, seizure, skin/nail pigmentation changes (blue), Stevens-Johnson syndrome, syncope, taste perversion, toxic epidermal necrolysis, tremor, urticaria, vertigo",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F235131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Life-threatening hypersensitivity to zidovudine or any component of the formulation",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Neutrophil count &lt;750/mm",
"     <sup>",
"      3",
"     </sup>",
"     or hemoglobin &lt;7.5 g/dL (4.65 mmol/L)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F235114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fat redistribution: May cause redistribution of fat (eg, buffalo hump, peripheral wasting with increased abdominal girth, cushingoid appearance).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic toxicity:",
"     <b>",
"      [U.S. Boxed Warning]: Hematologic toxicity, including neutropenia and severe anemia have been reported with use.",
"     </b>",
"     Toxicity may be related to duration of use and prior bone marrow reserve. Use with caution in patients with bone marrow compromise (granulocytes &lt;1000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or hemoglobin &lt;9.5 mg/dL); dose interruption may be required in patients who develop anemia or neutropenia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immune reconstitution syndrome: Patients may develop immune reconstitution syndrome resulting in the occurrence of an inflammatory response to an indolent or residual opportunistic infection during initial HIV treatment or activation of autoimmune disorders (eg, Graves&rsquo; disease, polymyositis, Guillain-Barr&eacute; syndrome) later in therapy; further evaluation and treatment may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lactic acidosis/hepatomegaly:",
"     <b>",
"      [U.S Boxed Warning]: Lactic acidosis and severe hepatomegaly with steatosis have been reported with nucleoside analogues, including fatal cases.",
"     </b>",
"     Risks may be increased with liver disease, obesity, pregnancy, prolonged exposure, or in females. Suspend treatment in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or hepatotoxicity (transaminase elevation may/may not accompany hepatomegaly and steatosis).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myopathy:",
"     <b>",
"      [U.S. Boxed Warning]: Prolonged use has been associated with symptomatic myopathy and myositis.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Hematologic toxicity may be increased due to increased serum concentrations in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment; dosage adjustment recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Interferon alfa/ribavirin: Use with caution in combination with interferon alfa with or without ribavirin in HIV/HCV coinfected patients; monitor closely for hepatic decompensation, anemia, or neutropenia; dose reduction or discontinuation of interferon and/or ribavirin may be required if toxicity evident.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Zidovudine-containing products: Do not administer with combination products that contain zidovudine as one of their components (eg, COMBIVIR&reg; [lamivudine and zidovudine] or TRIZIVIR&reg; [abacavir sulfate, lamivudine, and zidovudine]).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F235195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2A6 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F235119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acyclovir-Valacyclovir: May enhance the CNS depressant effect of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clarithromycin: May enhance the myelosuppressive effect of Zidovudine. Clarithromycin may decrease the serum concentration of Zidovudine. Management: Monitor response to zidovudine closely when used with clarithromycin, and consider staggering zidovudine and clarithromycin doses when possible in order to minimize the potential for interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOXOrubicin: May enhance the adverse/toxic effect of Zidovudine. DOXOrubicin may diminish the therapeutic effect of Zidovudine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOXOrubicin (Liposomal): May enhance the adverse/toxic effect of Zidovudine. DOXOrubicin (Liposomal) may diminish the therapeutic effect of Zidovudine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ganciclovir-Valganciclovir: May enhance the adverse/toxic effect of Reverse Transcriptase Inhibitors (Nucleoside). Hematologic toxicity is of specific concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Interferons: May enhance the adverse/toxic effect of Zidovudine. Interferons may decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: May increase the serum concentration of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May decrease the serum concentration of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ribavirin: Zidovudine may enhance the adverse/toxic effect of Ribavirin. Specifically, the risk/severity of anemia may be increased.  Management: Due to significantly increased risk of anemia, consider even closer monitoring for anemia than routinely recommended for ribavirin.  Alternative therapies should be considered when clinically possible, particularly for patients with other risk factors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of Zidovudine.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Rifabutin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Stavudine: Zidovudine may diminish the therapeutic effect of Stavudine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F235121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F235135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. Zidovudine crosses the placenta and the placenta also metabolizes zidovudine to the active metabolite. No increased risk of overall birth defects has been observed following first trimester exposure according to data collected by the antiretroviral pregnancy registry. The pharmacokinetics of zidovudine are not significantly altered in pregnancy and dosing adjustment is not needed. The DHHS Perinatal HIV Guidelines consider zidovudine the preferred NRTI for use in combination regimens during pregnancy. The use of zidovudine has been shown to reduce the maternal-fetal transmission of HIV by ~70%. Zidovudine should be administered I.V. near delivery regardless of antepartum regimen or mode of delivery in women with HIV RNA &gt;400 copies/mL or unknown HIV RNA status. In HIV-infected mothers not previously on antiretroviral therapy, and who do not need therapy for their own health, treatment may be delayed until after the first trimester; however, earlier initiation of therapy may be more effective in reducing perinatal transmission.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Cases of lactic acidosis/hepatic steatosis syndrome related to mitochondrial toxicity have been reported in pregnant women with prolonged use of nucleoside analogues. It is not known if pregnancy itself potentiates this known side effect; however, women may be at increased risk of lactic acidosis and liver damage. In addition, these adverse events are similar to other rare but life-threatening syndromes which occur during pregnancy (eg HELLP syndrome). Hepatic enzymes and electrolytes should be monitored in women receiving nucleoside analogues and clinicians should watch for early signs of the syndrome. In addition, mitochondrial dysfunction may develop in infants following",
"     <i>",
"      in utero",
"     </i>",
"     exposure.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Regardless of CD4 count or HIV RNA copy number, all HIV-infected pregnant women should receive a combination antepartum antiretroviral (ARV) drug regimen; this includes women who require therapy for their own health, as well as women who do not yet require therapy for their own health. ARV therapy should be started as soon as possible if required for the woman&rsquo;s health. health. Although earlier initiation may be more effective in reducing the perinatal transmission of HIV), also consider maternal conditions (eg, nausea and vomiting) and the potential risks of first trimester fetal exposure for specific agents. Plasma HIV RNA levels should be assessed at ~34-36 weeks gestation in order to help determine mode of delivery. If ARV therapy must be interrupted for &lt;24 hours during the peripartum period, stop then restart all medications simultaneously in order to decrease the chance of developing resistance. Long-term follow-up is recommended for all infants exposed to ARV medications.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Healthcare providers are encouraged to enroll pregnant women exposed to antiretroviral medications in the Antiretroviral Pregnancy Registry (1-800-258-4263 or www.APRegistry.com). Healthcare providers caring for HIV-infected women and their infants may contact the National Perinatal HIV Hotline (888-448-8765) for clinical consultation (DHHS [perinatal], 2012).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F235164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F235136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Concentrations of zidovudine in breast milk are similar to those in the maternal serum. Maternal or infant antiretroviral therapy does not completely eliminate the risk of postnatal HIV transmission. In addition, multiclass-resistant virus has been detected in breast-feeding infants despite maternal therapy. Therefore, in the United States, where formula is accessible, affordable, safe, and sustainable, and the risk of infant mortality due to diarrhea and respiratory infections is low, complete avoidance of breast-feeding by HIV-infected women is recommended to decrease potential transmission of HIV (DHHS [perinatal], 2012).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F235137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F235134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Retrovir Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $323.83",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Zidovudine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $201.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Retrovir Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/mL (20 mL): $35.03",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Syrup",
"     </b>",
"     (Retrovir Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg/5 mL (240 mL): $77.71",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Zidovudine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     300 mg (60): $360.97",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F235123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor CD4 count (every 3-6 months; every 6-12 months once clinically stable); viral load (2-8 weeks after initiation/modification of therapy, and then every 3-6 months); CBC with differential (every 3-6 months); liver function tests (every 6-12 months); lipids, glucose (yearly if normal); observe for appearance of opportunistic infections [DHHS [adult], 2012])",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F235138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adovi (ID);",
"     </li>",
"     <li>",
"      Antivir (TH);",
"     </li>",
"     <li>",
"      Aviral (CO);",
"     </li>",
"     <li>",
"      Avirzid (ID);",
"     </li>",
"     <li>",
"      Azidomine (KP);",
"     </li>",
"     <li>",
"      Kedu (CL);",
"     </li>",
"     <li>",
"      Retrovir (AE, AR, AT, AU, BB, BE, BG, BH, BM, BS, BZ, CH, CY, CZ, DE, DK, EE, EG, ES, FI, FR, GB, GR, GY, HK, HN, ID, IE, IL, IN, IQ, IR, IT, JM, JO, KW, LB, LY, MT, MY, NL, NO, NZ, OM, PH, PL, PT, PY, QA, RU, SA, SE, SK, SR, SY, TH, TR, TT, TW, UY, VE, YE);",
"     </li>",
"     <li>",
"      Retrovir-AZT (BR, CN, MX, PE);",
"     </li>",
"     <li>",
"      T-Za (TH);",
"     </li>",
"     <li>",
"      Timivudin (MX);",
"     </li>",
"     <li>",
"      Zidovir (IN);",
"     </li>",
"     <li>",
"      Zydowin (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZA, ZM, ZW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F235113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Zidovudine is a thymidine analog which interferes with the HIV viral RNA-dependent DNA polymerase resulting in inhibition of viral replication; nucleoside reverse transcriptase inhibitor",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F235130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Significant penetration into the CSF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     : 1-2.2 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Relative diffusion from blood into CSF: Adequate with or without inflammation (exceeds usual MICs)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CSF:blood level ratio: Normal meninges: ~60%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 25% to 38%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via glucuronidation to inactive metabolites; extensive first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 54% to 74%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Terminal: 0.5-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 30-90 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Urine (72% to 74% as metabolites, 14% to 18% as unchanged drug)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Urine (45% to 60% as metabolites, 18% to 29% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 82.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bendayan R, Georgis W, and Rafi-Tari S, &ldquo;Interaction of 3&prime;-Azido-3&prime;-Deoxythymidine With the Organic Base Transporter in a Cultured Renal Epithelium,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1995, 15(3):338-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7667167/pubmed\" id=\"7667167\" target=\"_blank\">",
"        7667167",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carpenter CC, Fischel MA, Hammer SM, et al, &ldquo;Antiretroviral Therapy for HIV Infection in 1997. Updated Recommendations of the International AIDS Society - USA Panel,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1997, 277(24):1962-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/9200638/pubmed\" id=\"9200638\" target=\"_blank\">",
"        9200638",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to  HIV and Recommendations for Postexposure Prophylaxis,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2005, 54(RR-9):1-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/16195697/pubmed\" id=\"16195697\" target=\"_blank\">",
"        16195697",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Collins JM and Unadkat JD, &ldquo;Clinical Pharmacokinetics of Zidovudine: An Overview of Current Data,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1989, 17(1):1-9.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, &ldquo;Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, Department of Health and Human Services,&rdquo; February 12, 2013;1-267. Available at",
"      <a href=\"file://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?GuidelineID=7&amp;ClassID=1\" target=\"_blank\">",
"       file://www.aidsinfo.nih.gov",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DHHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, &ldquo;Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, Department of Health and Human Services,&rdquo; August 11, 2011; 1-268. Available at",
"      <a href=\"file://www.aidsinfo.nih.gov\" target=\"_blank\">",
"       file://www.aidsinfo.nih.gov",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DHHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, \"Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States,\"  July 31, 2012. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      D'Silva M, Leibowitz D, and Flaherty JP, &ldquo;Seizure Associated With Zidovudine,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1995, 346(8972):452.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fischl MA, Richman DD, Hansen N, et al, &ldquo;The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects With Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection. A Double-Blind, Placebo-Controlled Trial. The AIDS Clinical Trials Group,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1990, 112(10):727-37.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gill PS, Harrington W, Kaplan MH, et al, &ldquo;Treatment of Adult T-Cell Leukemia-Lymphoma With a Combination of Interferon Alfa and Zidovudine,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1995, 332(26):1744-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7760890/pubmed\" id=\"7760890\" target=\"_blank\">",
"        7760890",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gorman SE, Dela Cruz F, and Paloucek F, &ldquo;Ketoconazole and Zidovudine Overdose,&rdquo;",
"      <i>",
"       Am J Emerg Med",
"      </i>",
"      , 1995, 13(1):115-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7832939/pubmed\" id=\"7832939\" target=\"_blank\">",
"        7832939",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hagler DN and Frame PT, &ldquo;Azidothymidine Neurotoxicity,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1986, 2(8520):1392-3.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hargreaves M, Fuller G, Costello C, et al, &ldquo;Zidovudine Overdose,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1988, 2(8609):509.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hermine O, Bouscary D, Gessain A, et al, &ldquo;Brief Report: Treatment of Adult T-Cell Leukemia-Lymphoma With Zidovudine and Interferon Alfa,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1995, 332(26):1749-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7760891/pubmed\" id=\"7760891\" target=\"_blank\">",
"        7760891",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hilts AE and Fish DN, &ldquo;Dosage Adjustment of Antiretroviral Agents in Patients With Organ Dysfunction,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1998, 55:2528-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/9853641/pubmed\" id=\"9853641\" target=\"_blank\">",
"        9853641",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hoggard PG, Veal GJ, Wild MJ, et al, &ldquo;Drug Interactions With Zidovudine Phosphorylation",
"      <i>",
"       in vitro",
"      </i>",
"      ,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1995, 39(6):1376-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7574535/pubmed\" id=\"7574535\" target=\"_blank\">",
"        7574535",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ioannidis JP, Cappelleri JC, Lau J, et al, &ldquo;Early or Deferred Zidovudine Therapy in HIV-Infected Patients Without an AIDS-Defining Illness,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1995, 122(11):856-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7741372/pubmed\" id=\"7741372\" target=\"_blank\">",
"        7741372",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kinloch-De Loes S, Hirschel BJ, Hoen B, et al, &ldquo;A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1995, 333(7):408-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7616989/pubmed\" id=\"7616989\" target=\"_blank\">",
"        7616989",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Marchbanks K, Dudley MN, Posner MR, et al, &ldquo;Pharmacokinetics and Pharmacodynamics of High-Dose Zidovudine Administered as a Continuous Infusion in Patients With Cancer,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1995, 15(4):451-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7479197/pubmed\" id=\"7479197\" target=\"_blank\">",
"        7479197",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McLeod GX and Hammer SM, &ldquo;Zidovudine: Five Years Later,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1992, 117(6):487-501.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/1503352/pubmed\" id=\"1503352\" target=\"_blank\">",
"        1503352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Morris DJ, &ldquo;Adverse Effects and Drug Interactions of Clinical Importance With Antiviral Drugs,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1994, 10(4):281-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/8018300/pubmed\" id=\"8018300\" target=\"_blank\">",
"        8018300",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mueller BU, Jacobsen F, Butler KM, et al, &ldquo;Combination Treatment With Azidothymidine and Granulocyte Colony-Stimulating Factor in Children With Human Immunodeficiency Virus Infection,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1992, 121(5 Pt 1):797-802.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/1279153/pubmed\" id=\"1279153\" target=\"_blank\">",
"        1279153",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Newell ML and Gibb DM, &ldquo;A Risk-Benefit Assessment of Zidovudine in the Prevention of Perinatal HIV Transmission,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1995, 12(4):274-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7646826/pubmed\" id=\"7646826\" target=\"_blank\">",
"        7646826",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rachlis A and Fanning MM, &ldquo;Zidovudine Toxicity: Clinical Features and Management,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1993, 8(4):312-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/8481217/pubmed\" id=\"8481217\" target=\"_blank\">",
"        8481217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Skowron G, Bozzette SA, Lim L, et al, &ldquo;Alternating and Intermittent Regimens of Zidovudine and Dideoxycytidine in Patients With AIDS or AIDS-Related Complex,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1993, 118(5):321-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/8094279/pubmed\" id=\"8094279\" target=\"_blank\">",
"        8094279",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Taburet AM, Naveau S, Zorza G, et al, &ldquo;Pharmacokinetics of Zidovudine in Patients With Liver Cirrhosis,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1990, 47(6):731-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/2357867/pubmed\" id=\"2357867\" target=\"_blank\">",
"        2357867",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Volberding PA, Lagakos SW, Grimes JM, et al, &ldquo;A Comparison of Immediate With Deferred Zidovudine Therapy for Asymptomatic HIV-Infected Adults With CD4 Cell Counts of 500 or More Per Cubic Millimeter. AIDS Clinical Trials Group,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1995, 333(7):401-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/7616988/pubmed\" id=\"7616988\" target=\"_blank\">",
"        7616988",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Volberding PA, Lagakos SW, Koch MA, et al, &ldquo;Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection. A Controlled Trial in Persons With Fewer Than 500 CD4-Positive Cells Per Cubic Millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1990, 322(14):941-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/1969115/pubmed\" id=\"1969115\" target=\"_blank\">",
"        1969115",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wyles DL and Gerber JG, &ldquo;Antiretroviral Drug Pharmacokinetics in Hepatitis with Hepatic Dysfunction,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 40(1):174-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/28/24008/abstract-text/15614709/pubmed\" id=\"15614709\" target=\"_blank\">",
"        15614709",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10053 Version 47.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-18D72DAC39-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24008=[""].join("\n");
var outline_f23_28_24008=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708846\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235151\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235152\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235202\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235156\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235179\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235157\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235158\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235159\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011337\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235125\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235110\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235128\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235209\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235126\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235198\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235211\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235200\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235131\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235114\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235195\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235119\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235121\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235135\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235164\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235136\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235137\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235134\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235123\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235138\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235113\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235130\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10053\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10053|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/25/22933?source=related_link\">",
"      Zidovudine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/55/27512?source=related_link\">",
"      Zidovudine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_28_24009="Postadolescent acne on chin";
var content_f23_28_24009=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81177%7EPC%2F81886&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81177%7EPC%2F81886&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Postadolescent acne in an adult female",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inflammatory papules and pustules are present on the chin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Postadolescent acne",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 280px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Characteristic location of acne along the jaw line in a woman. Multiple papules have been excoriated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24009=[""].join("\n");
var outline_f23_28_24009=null;
var title_f23_28_24010="Medullary syndrome";
var content_f23_28_24010=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F73073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F73073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Medullary syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 698px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kistler, JP, et al, Cerebrovascular Diseases, Harrison's Principles of Internal Medicine, 13th ed. McGraw-Hill, New York 1994. Copyright 1994 McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24010=[""].join("\n");
var outline_f23_28_24010=null;
var title_f23_28_24011="Prevent prosthetic jt infection";
var content_f23_28_24011=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F61121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F61121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    General principles of prevention of prosthetic joint infections",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Preoperative antimicrobial prophylaxis with cefazolin (1 g if less than 80 kg and 2 g if more than 80 kg) or cefuroxime (1.5 g) given intravenously at the",
"induction of anesthesia and repeated for two doses postoperatively at",
"eight hour intervals, respectively. If patient is at high risk for",
"MRSA, vancomycin (1 g intravenously at the induction of anesthesia and",
"repeated once postoperatively at twelve hours).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patients with type I allergy to beta-lactams should receive prophylaxis with vancomycin (1 g intravenously at the induction of anesthesia and repeated once",
"postoperatively at twelve hours) or, in patients who are allergic to or",
"cannot tolerate vancomycin, clindamycin (600 to 900 mg intravenously",
"and repeated twice postoperatively at eight hour intervals).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Careful preoperative evaluation for occult infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Taper or discontinue immunosuppressive medications if possible",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any local (eg, wound) or systemic infection should be quickly eradicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prophylactic antibiotics for patients with a prosthetic joint undergoing a procedure associated with significant bacteremia should be given only if there are other indications such as heart valve disease requiring endocarditis prophylaxis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24011=[""].join("\n");
var outline_f23_28_24011=null;
var title_f23_28_24012="Common benzodiazepines for treatment of procedural anxiety";
var content_f23_28_24012=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F71754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F71754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common benzodiazepines for treatment of procedural anxiety in adult patients*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Benzodiazepine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Oral dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Initial parenteral dose",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onset",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diazepam",
"       </td>",
"       <td>",
"        10 mg",
"       </td>",
"       <td>",
"        0.03 to 0.1 mg/kg IV (2.5 to 10 mg per dose)",
"       </td>",
"       <td>",
"        Rapid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alprazolam",
"       </td>",
"       <td>",
"        0.5 mg immediate release",
"       </td>",
"       <td>",
"        Not available",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lorazepam",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        0.02-0.044 mg/kg IV (2 to 4 mg per dose)",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Midazolam",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        Not recommended",
"       </td>",
"       <td>",
"        0.02 to 0.03 mg/kg IV (0.5 to 2 mg per dose)",
"       </td>",
"       <td>",
"        Rapid",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Approximately 50 percent dose reduction is needed for older or debilitated adults, patients with low cardiac output or those premedicated with opioid analgesics. In addition, if dose is administered intravenously, a slower rate of administration and less frequent dosing should be used.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      Equipment, medications, and personnel skilled in advanced cardiac life support and with knowledge of the effects of sedatives and reversal agents must be available for intravenous administration. See topics on procedural sedation.",
"      <br>",
"       &Delta; Repeated dose(s) equal to or one-half of initial dose may be needed 30 to 60 minutes after oral administration or 5 to 30 minutes after intravenous administration, based upon response.",
"       <br>",
"        <font class=\"lozenge\">",
"         &loz;",
"        </font>",
"        For prevention of anxiety associated with non-invasive procedures (eg magnetic resonance imaging), 5 mg/mL midazolam injection solution&nbsp;may be administered intranasally&nbsp;at a dose of 1 to&nbsp;4 mg",
"        <sup>",
"         [3]",
"        </sup>",
"        . The injection solution is irritating to nasal passages. See text.",
"        <br/>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Lexicomp Online. Copyright &copy; 1978-2013 Lexicomp, Inc. All Rights Reserved.",
"       </li>",
"       <li>",
"        Gan TJ. Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet 2006; 45:855.",
"       </li>",
"       <li>",
"        Hollenhorst J, Munte S, Friedrich L, et al. Using intranasal midazolam spray to prevent claustrophobia induced by MR imaging. AJR 2001; 176:865.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24012=[""].join("\n");
var outline_f23_28_24012=null;
var title_f23_28_24013="IMA versus vein graft patency after CABG";
var content_f23_28_24013=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Graft patency after CABG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 250px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patency of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. The 10-year patency rate was significantly higher with the arterial grafts. There was a variable number of patients studied at each interval, accounting for the irregular shape of the curves.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Loop FD, Lytle BW, Cosgrove DM, et al, N Engl J Med 1986; 314:1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24013=[""].join("\n");
var outline_f23_28_24013=null;
var title_f23_28_24014="Serum prolactin by dx";
var content_f23_28_24014=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F72540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F72540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Ranges of serum prolactin concentrations in several causes of hyperprolactinemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 424px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The serum prolactin concentration is much higher in most patients who have lactotroph macroadenoma than in patients with any other cause of hyperprolactinemia. The prolactin concentrations among other causes overlap with each other.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Tyson JE, Hwang P, Guyda H, Friesen HG. Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 1972; 113:14.",
"       </li>",
"       <li>",
"        Kleinberg DL, Noel GL, Frantz AG. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.&nbsp;N Engl J Med 1977; 296:589.",
"       </li>",
"       <li>",
"        David SR, Taylor CC, Kinon BJ, Breier A. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther 2000; 22:1085.",
"       </li>",
"       <li>",
"        Rivera JL, Lal S, Ettigi P, et al. Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin Endocrinol 1976; 5:273.",
"       </li>",
"       <li>",
"        McCallum RW, Sowers JR, Hershman JM, Sturdevant RA. Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab 1976; 42:1148.",
"       </li>",
"       <li>",
"        Mancini AM, Guitelman A, Vargas CA, et al. Effect of sulpiride on serum prolactin levels in humans.&nbsp;J Clin Endocrinol Metab 1976; 42:181.",
"       </li>",
"       <li>",
"        Sowers JR, Sharp B, McCallum RW. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab 1982; 54:869.",
"       </li>",
"       <li>",
"        Steiner J, Cassar J, Mashiter K, et al. Effects of methyldopa on prolactin and growth hormone.&nbsp;Br Med J 1976; 1:1186.",
"       </li>",
"       <li>",
"        Lee PA, Kelly MR, Wallin JD. Increased prolactin levels during reserpine treatment of hypertensive patients.&nbsp;JAMA 1976; 235:2316.",
"       </li>",
"       <li>",
"        Fearrington EL, Rand CH Jr, Rose JD. Hyperprolactinemia-galactorrhea induced by verapamil. Am J Cardiol 1983; 51:1466.",
"       </li>",
"       <li>",
"        Veldhuis JD, Borges JL, Drake CR, et al. Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man.&nbsp;J Clin Endocrinol Metab 1985; 60:144.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24014=[""].join("\n");
var outline_f23_28_24014=null;
var title_f23_28_24015="DM testing living donors";
var content_f23_28_24015=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75300&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75300&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diabetes mellitus testing of living kidney donors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 475px; background-image: url(data:image/gif;base64,R0lGODlhogHbAcQAAP///0BAQMDAwICAgAAAAPDw8NDQ0ODg4DAwMKCgoGBgYCAgIHBwcFBQULCwsJCQkBAQEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACiAdsBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fo8uCP6AgYKDhIWGh4iJiouMjY6PkJGGBXyVLAIQAZqbnJ2en6ChoqOkpaanqKmqq6yfEAKWsSgCAbK2OAGwt7e0u74yub+yvcLFK8HGfMQiB4AkBpQmtUwJCQAMBgC6RQXZMQ4BDC613ScHBzTVQMjJessAAwEDDAjW194lBMfbPQMDAMFqvWsxMIU+AAbEwTiwoEA0FvoSnlA3w986fu3uvLMIoAACWAnQMdDkQASBBOFE/xRQIA8AQwX/VrYEAC5ASRIDwDGQqSueAkoWg/0bsGCAM3gi4jXAB68oLHBLO7L8KYDAgJDWBDhgqUtAgwYD0I0gavQAS3sJDDzgp+9AggL/kvoB6eArOrjh7I0wqylmvAGUtHIV4bVBzwNha94UwS6jxmlJ4wJI0ADg044L0BGA1eABgI/XACNY+xkWgwEGGrrNZ81u6tA0awWFpS/BR8Rx9T2obGDx5Nt1CzAs0JmmgQObDfSKd+D1AQQHPPKzLYChAOLWAjgloa/Xgmyvg+58oAA2yhKgYQJQP6A8c+eZGWqW50C1XsuO82yU3CuYgJGvAHAQLan5wxJ+BbYXwP8BEJCWT2QmAQCBPwPoM5uA2kzDUW31MJWhCA3ARJQACjTggFgDypYbAA8o1FgvBkzjFX4P9kLeetZc2AsEgUGGEAIQQjCCkBuyGNcAnh3EoIMjNJYfHfuNkIA4uTiAQDbBpCjAR39gCcuWgGSDGAI+YgjPips5c2F3Gq6oDQNFkUBMAGv9QUkCCgSY4pkRcvSiQDLW4iSGvRTQUEN8+lfLniMQY9FBGBbJ0aN7DUAmCYM+GUeUCGVm2TwdgXYQAw8UAIE3WJZkKqrndARphHxiSKcI2aypDZAsioMcQpSAIyeuA1TWUTMinCZgj7Hq42tpck7DIzyeDcqmCFNBqCj/s8uq9KyxJmpTWZEG4BpANkre9Wqmmr6x0QIBIBCVZR4F0ICo7f70Y7v/WFlLuPg+1+59ZhZJHALuJkobYwG8xS4DypJ5ZQmaWENPu2NqAhQCDCznJj0KLMAPMVYiYK+0HyJEgFg67utuA2Xa9tU/MWpSq5uWIuCmv/VgilG6cBTEMwnReJpENHgqge7Pa/iMNADs5qxEAuwG8NARRy+NhtJW81F11mVgzXUeW38thtdi2xF22V+AKcnabLft9ttwxx0JaGinEXMreOetdyoE7O3334Bv4mHdhFfxauGIJw7E4Yo37rgNjD8u+eQQUW755QZhrvnmkW/uueKdfy56/92hj1524Kinrjorfa/u+uuwbwIw4mnKbfvttj/AJe689+472+o5Xnq6ZJs+lmSgl1288bE2PrymyxvPkfPKl8n8CdMnL3b0pmef+PNPcj+693U3U1WXViunu53Xm/CHAgqwT3hVBNRvldUM20/A4NcHoD/4SPvfzjTlAP0JqX0lqJD9hFW4BugvawXQX3kQKCf9eQZxD1gg1/xXv9khEAL245/YDGC/C1pNgSejYAkcSIADJm4B9RMh9Oq3ABWWIIMEmGDiFECAGn4NhAqxIa062LgE5FBsDvSNEGEolsQhx4M/y+DUhNixx0FnhLgSopSCqDglZs2LNvSDFsdIxv8ymlGFc/kd25pIBTWqkY14UI4b13YGTMQOb3GyQuvuqLo86qFdfGRdHa1XBfJFAYBaMGQdzuYERGJBfEtQ5BMciQVJzoGRTaCkFSCpBEtmEg2ejAMmmaDJKnDSJQKQYQuUA7TqmCCUS3iVHKc4BGzwqiLIw8MoG3WdGjRjiqk0QSnbWCaibAIgDstGAQIAEwU8rAXGKlYD6MGMoiBAibBUwqugpgA4MmaAuDAN/4aXTTc4aY8JsCPGRGAbf6yzBQwawW6IchMrIUmYg0wg8oJhACElbATCSUECbqIdyRzQMNBCSDFzKYXDBcMt8fDMS2DGspuEJSwD/QpeLmiAihL/5isem4xISKINq1ijozbBCUPNhpFXEaMzW3qIh5gkJf8BVAS+MhQtYdW1herMVQxhAV4AczzCtIlGhysnEhz6JY8ZKjqjqQ50lkkbeRwgHAVY31OfE51ccFU6+FFVfJLzVXYolQ3nbFax2gNFZpwFnyWgzGQ6Exa49jSBUcvOWqZJjAT4g40y8SJHHPUPZCR1pVBgaskCAosHyOMvZsLPnATgWH/Io0XflCyADsaix86keWBr6THBBLWrwgI3HsyqzbhTAkPVyiYOgAAchzmFgWSPmTnpFK3ABDSWCDYuhEWqPq+g2Mnipz2A0EyTvjSNXCD3D7jJbJUelqWkxA+6/0XdQ1obVZQHoKMB1vCDY0+gWuS9yiP2mFQuaSsF2+6TH//MbGv/8pDpHRQW94zRcPUIMeZKtyQCQBRCInstywQ4Gr2ZBmicKw6wEiAwAsbHWdewXaP+KhoD4cvsIIXeESxLAQBjbxTc+9MRxKiZz5yIRfsiTWq6xJrYROwkScAACFzJuPr6TbtKAqkCB8M2O76GyBZ8HTLNC7/rBPI1s/vHlqoVJzazFBdZtDMBVMgoAJgXhailAHpMUcRQyDAboWGCZngzBYEwMT/84M0JFwHMUHBzGpy0Zv794QXmc6Uc70yrceazzME8AptfKeNGgrLQcsiU/IzASruSYSDLRP9xzBYQNU1QWhMuiKaJA8QQS8WYuIfWGkbaKWWU+K8TrWsrCeIJtNVeY5pZHAGcnTCQ+A4LQkxGwUAZ40fMgCa/PuXvGeSMhhchQKayfpAJaMpOm2JqJvdV9l334kNCqxQFQ62vZJYZI1gYdr+GC7V2+QFiFBwuchp2NIgtElzWmuEdff0rrucNUN9aG0QlYSxP6T2F2s3RdsFr8k9Rm2x3k1d35pWnONh9VIM/2kevQQhvQUu+wN57S/5YQDe/fW0rwA4BmXidqhPND/B2hLKQOXcKymvwCcUjF+0u+LSbpBdkZE+R2c5uGkcDF8/ot+P6IeTpPnZsC+87sqt+q7T/AQE/dETb4WMYyInb88ybI3rX8GDxwGEMbjyc8klOspQ7g6jyZVf5yvzgCANg7eioE9LMq2Zjq1yQ5mdEY9Bdf4ziFI2RvuM5uXFX8wlm3YSvH4HY7xa62HapzT9nAfEzLxzjk0B4JhjeCJB/+N7B2W/HVxLRPVP81ya/VM9fIfNu3/wWKr+EyxcB9WMT/QY531DTWwH2YXB9O0h/BNYrQfdDwD0YgG8M3hvB90kgfhCEnzbZZ834b7Z98mnPfC8oXxjQT+AK+PwC5CPBa+qc8g4sWf0uXP8XVbNjxCqngrN6/wjgn0ZnuiHGrJZKJQ9ADTuxvP9t+DXg2AN66uJ8/1aTfhAnFs3REflHLi4hFv7XHsB1FewXee4zDacRYGRiKNXQEB7xAHWxHkaRUjBBCyUBFrRQaOXHBefnC+m3O80RH9/RgR9oIW5igi1BGf8hftKmeWj2EaUVU5OhEAxQDTpkHShnhI4VVKB1b0GnemhWFP4AEmRiDUWTbEWihBaxAA7wB8PzfkYAft2FDu1GIfwBhVcRYBSSTg2HAim4BSu4CwYoDcKSPTQYIcFlFVumAl5YBPH3ZB+4Hg5wHsPyLIN4d1iIggLoBm94C3FIAqZGhdNACXWIIYfINLqwU1AXeyoAb5DBTAcCEDABJFDTHuUxivCzHtP0WQG4B4toC//pZ4appBrfAYqWQokT4kDUkoowswAM4GKZk3gqUA4AxRQGQIzb4Af4gIwmdg5nlmt6lzhVk0bVcRzMgCpdwQxfsoxzpw20d3SamEiJ2AatKAvZNwR7SATjmANtqAXpaAnlKATnOATteAPrmAXzKGqrJ31UUI+PRIBL845BEI9CcI81wI9XQJACpwUCGQTqF0ip0GvPiDiA5JB8cwbS+G+O0IxzgJB5sGcY6QhnlHv+GJIkOYAleZJNiJIqCSUjuZIu+Y0vGZNJ05IyWZP2SJM2mZPEpJM8KZI9+ZPmh5NAOZTwJ5REeZQDaZRI2ZEU2ZR3BHJOGZVSuTcj9zVq85H/WOk765OVXNmVwBOOS8ORm6KUmGOQliCWoWdGZlkJaGmSZbSWykCWvtCWSAOXrCiXu0CXP2OX7oCXvOCXk8OXd6A+XKKRjkGYi0ZB73NdiINC9dON7ZA/IbRE+lNtdUM/9eNCSFNA9qOZFMRD9qNDhKM/DIQ0ERSaWsSZRIQ4LEQAJvSP9lOVonOa9YOJX4ND+8M1KGSYxoMA9RNrhENCPWSVNERG+aODaANComk1QERG9ANGaMNDsukYSVRG9eM4RsSbTyJFZYRpjfMcZRMuZpR/jzOd+QGdFFSMS7me7Nme7okCeeaVk4AF8SmfkjCY9sk2qlRJlTaVrgCZTGBM//6JNwsJBRM5oKtwKWEgmOMAoJEElqDGUsC4oBCKBADZDxUabhJKgV3AoC1woTzgoTpQoE8AoskHmEgwYcqhnZtojNLgoJ0kGfEpca6kEn7lXebwEIhxf/2XAh4SHZXCo94oStsQCNFxFMyQf29xAj+qo0iCiQGVpPrnYfxXMmBwW2SSEntECeFyGvPiAlQ1AhgzTS0GnCaqA9PzF0ERiie1AOmEEmtWH5eoheMFD/FDN88wEgAlpypBpz5Cok7ADnhoFGjoZb+xhQ9gmS5hRHsaUpjhAHVaAic4AkPIpwBhFPiglzRwW2whArvhWia2cg8AHgEQIN4iAgf0dPJ1e/+SwamuwjRMMTWI4ahbIQKIckVTYgJ4Ahmzqgu1yjQPAahNIKhPdhrDcVNyUiGVQqsTJGA4oYoQUoVPdqXv5W7gIK0pkG7LhWswt4Y0wqpjcV3o8FCnApwnYHNxUV1WOq3y5SfbIKxMIKjOQAwK8ACYtQKKFSuZQj7/FCLyUqQoenj7lKXkohXXpF65dGKDg67fFHPfWkit+ljeBhNuSgwjMS4vyq2c1QsX6w211hPp+q53IKhbhobOBBfp6p07SCPuChAq6z2COCupgWEBi3nVKmv+kA03wo2Ho7AZq69/4K1nqo6tuk9rQQmstqrbaiSMkQ0HNCMV2F+emq74AK//S0CsjfIR3iBXMgd1yECeAME/2WMb0YAMyKCpuFRi+waqQ6qt8gW1qQoi8AWjSZCmN8tlS1ti4mkq+HYNr9koZYIMe6uZVms0Igu4JeCmXbu4ggskfLuK7FR0nloepkKzYuCqi2slXmquADWqLkEU5fYZayeEbKe2EJtrjYEXmtBNz1Cq70QPTsMvUmMC9JAJpGpjQkgw91G4SYC1RrcXLKEJU4YSfXNSrpu7TgMxl2YSWZq7toa2MpA9ZNYoTNpLLZBGmeqiUnt6GUoFvGuhdLtJNft63VsEQ4sDIpoD30s14WtK40sE6asC50uP5Vt7G8qD1JoF82sD8XsD62sE//srj+8bfPU7BAG8qQWcWCPbvjtJofrLwK93XfkJCf9rvnUywY4QqV/QvyhwwDNgaqsDla9zBxe7OpfmOsgJjg8cl2qZwG7AwecKwVczwI3pwm0Awz/bly0sDLA3FzzgweK7w7/gZuECAUIoD/QwJe0ScvvZwTKsjxSEw1IgZ44imh5LlkDsvkLsC1Q8DUIjqVj8xBNKRlIcBV0MK1bGf5eXxQ1MxjbMBmcsIejQDMGzxmLcA35Fhnq8x3zcx33cMX4cyIIcyOoyyIZ8yH1xyIocyCwaZ91bxdllx1SAW4tcyZZ8yX1cwSH6WJjcyZ58yI66BW5mFoorE/PgNJI8Bf9sfHxvUMY5sMppKwNzkYyBphJNLL93/MO5LGw3/MaTvMsEvMKqDMze28q+PMwdesy6/MtvoMnjp8xRAMvRC806IM1O3MzG/AbWDAOurLQGSsyd98LUXKLgDATd/LBNMBdRdctdYD5pws4qSCKMmQbqvBbwHKCc/Mn6zMeh7ATCiZppoJr1k8JhAEL2o6hl8M/1s5ybtM8UAsgOLW9RYNCr2Qf/g55h0JpHpAYUfRJeR8NPoNGN3AUcdJ1qgJserQYi/dFwgJucWwYoBNJJoNC2KQYunZJugBwDzQb/PM5LAEME8NJkoNMEQNBu+QZAjdFjYND3zAWgadRikNQ47Qb/oOkGDuSZaGBEm9EGoFnTR+0GRiTTS5BBpZkGOu0GBSTW+7jEJNUGEeTTTIAcf5sGCsoGb40HKJ1CbpBibPDFa0Aqb8DXdKDQCK0GcN0Eh70EDtDUXpDYVQDUG/2ekg0EoJnSk33ZPKDVDxYGd+M35jkEnU2VUhA4UM1ogfPZW6DTQm2Pu9M2AEhrrf2VDQU3GgzbcPPaZ+Cbpa3FaOrYl4CiHEx40Luu9MsGDFPO6Ajcvr19ym2/OTDcynfOM1BAqdfb7dXch7QD0I3dFFbdjBEXFFET7vIfneANHFxr3olS/wLC6+eMn0SpwiIRCMEy690J9rDdEJPe9F0P7G1r/0uIBiPdxgKyIHxiJdFwADdBYiNmPUoyix2hF5ET3M+WFbXAEN5QABAOxtcNVxZuo4vLb5vzDpvhHv8g2L8L4pbH4MUy10Mq4U1iJR8C2IOn4QsOVzLediiOOSIOENGlJNhF3Oet4vgxyx/+36SkM2coKLBA5EeH38oWDEyOdO4tjxFd5Ysc4C+w4yTyKIEBWUC+3Jso5CmFGJ8o5TneeMslHYJSEmSecjQeZmLO5gpS5HapplZ+533cz9r9p4yhHvUaycEG53DFtVYa4WD+i5k154S+DIfj5O626G7OhDZbBme64yX1D52mFTOh4IJeQbrwryQS6Xn33pllKs1lGP+hvriOThhbDRCoXuaGXreHvgOV7iOSwSQOgCT4sBpA9wTuJRkGEIU4AbkKLCViEYgmJuxj8ea+vlDAruxJQeyTTga1/swbbt3ZrQOrXtwpGo7mw9gvYEsN+gPRPesnUO7OjQPbzr9gXk5/ESIX8QLVju2dTrTpfgPrXpDtHo4csTvqgBKsGxvdglI3QfAf1QB6jsvkzt3Nbu3Z/txqTRAMT74vwBHfMQBGXA0N4Ac1ZOBuUVZS1VUhD1bj7gPoXuP0PmPaHvG/7fACW/HywEyxglBh2y2e6llIgvP3ikmVHnJ7A5GF5/N6A/Sk9Dd17etCnzdELwTuHj8oE7LfZFb/EkzmydWyJd8DF2kIUZUIWB4EWV8I/nYIXQ8EiwA/igDuP/D1hLD1iDD27F7xyMMRmGUodrpbEXZgtLIseMoC27zNAZnN5oTc6MvvcR8XK0EwquJMN+gwJaFkJcExe78PgSr4Kt/L2kz5b0/tmM/3m3/k4nz53Evpna/wbuDMKU9hoz/Noj/52Pz5gR/6ms/6pQ/4beD3bAh6wiglqC1UTQ3LMWNjKRHQmtA65u4DlhY1avD7ZLLbL78CEqFeI0orzO/NRkCb9VP8PaDQrqkGvmk/LD8E1n8/+4g8IaEN2QBd2WFV8zAYvYVVXsFMdzLHWWFSq5FzEDUrposE3f+Y/2sAAgsxEgdwoqm6sq37wi1DEkN847muIrSwA4EDG2oICCiOAkEAoFAICoPAwbDgJQAOg8H0SAZ+TMCBIDCMFbZBUrCILkyocLCumo0g9j3/pSBd9QkKOtAYDCLu4RHoJQoaoTAdKCAA6I1BQhKkGFSiFDw0IDTRjQFsAow1WqY2KaXQOeIUjjTI3uYkkCTh9roUkKz6DqfQEtgS70CiQDw4MDg0YRJpppieIDwUjJW6oo6hnraexJL/JLOQPKCjA49ksRMH1MYnq9ffLJ80NHXaYDI4Ue0TBBMFyhQAkKBJAwcKvSUc0zCVLVPlXuEjN0JORlw9CCTseGvAO5G45v8ROGSShT4AX068GXdglIGBKByMopJgARJpPBW4GoCAwRgDAY4esnjOnEiSgVY6muEJKiIBG6kmekDgKVaBRLrquFjPAAFeYPsUCni2DwSua+uQNQu25VsXYutBgFfXDgGHe+s0kPt3R963dAfDWpqxQUjEO1w51uEs8g7Ghr9SnqMYn8rMODh6hnGgcegXnc8ejny3NOvWrj2ndrz6Ne3atqHGRjz7hFUavn8DDy58OPHhmK0VT658OfMaLZpDj94csore0q9j/308R+4VB5Yo5oJCfAsDpE8wOJ1j9zjWqa+FTh0uNHxr1GFvx9FdxZQBDBDAEwAECRUAwX0ppLf/Ant2bVbdgZS992Bk8rVWXyQSOrZfCxoWQUQBCPyAhA0JAMXfAQMckIAJUzRwCB0OrLNeg/a1FmGN+YnDmoW8YYgYhyv8CMAyCdgSxhUg3kdAACiGEQoABjgUhgMQqAcDezuKtAR3OGLZkZb64TgfVCnmgGWXfZD5Ao5g1hHkMtwI0F994YSRAIAqBfDAAlVaOeOFZRo4FC4/2oiDAIGqJQuhYeqg5FHnDXKmgy1IqkIAOfXIIwxiKrMmDG5+lUBAYRSwwDZJapYKAwvYEMACCEDa5wuV/glAA9qY9wMo2qCQwAB+xamXr0v5qsaWlGZKo624bgPAriGBMoBKw/Y6/wCxbHjKH6M5oOKkGAn5ylGwCZ3IayoD6BXnFGVKSGuqkYTUxbkJnPokgSqdqMsJ0YIWQ5ApgHqCFSaUM6dm5mlBigAPwBqWn5oa6goD1r4aQKkJ7JTQEwIQRSTHAanBhEMNWLvksSy4297EboxyccYfOmNLyAE4NPPIJWcL8LY4oBLNKUgtidMPdi78gFEO2KlQAx+7tDQDyda6QspHPACeQpXgVADRD1St8DidIL1JAQEkgFO/aua8YdpF8IRAi0xBjAKdAuB0qYs/UBJrC1dCzRuIO33XsKjoqcjVAg4sUcIbC1MRyKLIlvl3HAIIrhYDGJt1wOIPNL4E55p7df/yCpy+YAZODpVAhicOJBEHCiFT7gbiVgHgespm9k2OGpA8sWft4nqdBjybeCyAsWwG8S9YfJfJ6gMmmJJJySnUMATF1icQ/dpCcpm7GwM83570b7I6RPblo6u96CqQ7kL1Kn3jCjiw7I5i9UbEzy7kMo4e43xwjiMWm+jPEB4GpO1pqzXMi5iyHIAMBTjgAAPaV0ycJUFogY5761PWDeBjCgeeAIIL2dcFSThBCzpuexTiFvv21YjBVbAAx3NWDH/Xng62K3cYed2qDhFDAArvBMSDjN5YgkCdKdCAt6PONZBQIiEtKQBcWAAD/qMQVj3BCQ14mgq7p7+oOdEVIqr/xE7YkIQyZlEBWzQZ8kbXqBYKJAD/MQFO2KANBKgBAVOsIhkRMAB+fFFqOhSREUaYtToqoGtXe1o/WDWDEC7pVhucJGUWeIMCnAaTnDjNdxrzJWedYTwHGCUlbxgDTX7iNOQR2FK20RlXipKUbYSjoaqTgu+kYBscQYMnl1IFVOJwfzhAg9WiIDCDCMAgKuECKpvly2TqQHmhc8FpHGCtrlgyPl50z87ok8MbtQlHKQoHA6CQJ3bEJpv4EaY2n1Ohb3IznJQiCTPI5Ra6AUUl0XhbiuL0JH6sQ4Zs/BUSyLGks+0QZTpEzTZLs8LS4A6cyfNUOE4opilgUg8OPIip/w5FMs2ZZx0gAsDETpGFBmRhY7FS52f00pSG6iBNJnmoMqAS0XhOtHQoYBgbLkqEMARmCItzxQMSZYUhlAgVRkinEqFGB/kt1AUJSqi/YOq+J6llai+YavtcQFOv2oCrg8DYNBmoUIkKgaK3PMNUphmGPIGnXhr0G3gOodQ1rCmbpDyIsw5hnjKcgQlxalC56DgEZQqsADD7AcKexZt8JfCsKNgrYocGou+E4ZoqKKzWwEcuOegqG2I4AWQfi67IujGVAuMNGUYj2lOUNpcPkNaTCsja1joBCgeRQ7iOyTXS3NShR+yQTlWA0gQWSEjIOIgp3JBYKq32rkJKlIKaWv8MWzDMJaNKXPpY5QBTceJwgyPKd+UaBs0Zi1QLwBh4CUCUkRJXsicAYXaLKo4BsGoJ3gXveMSbnqpxbq6bQK8NNkE5a3rjvYqhaXLJgslKHHYBxnJv7HKZDfoibqTSPQqKjBC0kQagITM0JQfbmVMWLERJWWACGwHWNr/851KYLcIobNGJSxU4dDORIguymdwQTyJKP8hfQhXg0gJYc6hMiUWdLJcF6cZXkLnUA5AhKI7milExRr6lrwZIBFQI0Al+QYAJoFxWWmLDAOXEWEA8fA4zK0QwcTKZdKU3k/mCQQxMhKdw5ckHafZBnSAysp0SQgciX6QcVqgaiJSCkcz/UiPHcz1ziQEwaIw1zMBQhRun7ZQ9LwsRbptg8pDP/NXLUUEB0NBgmCc96Q8RZcKhkx6WX+FBPps4rX0ANB/UyYCGFEAUTEG0lj0EiTA4mtQgFHOO9FEoFPzaAcH2hKYhdpHjje3NAhY1SWPUXlN3UwtbPILFWK1tV48QlEGR9FIjnVyFbNeUwc11p5I4q/scah9qeWoiHT3ZoZTzqA2ICRUH/oMpxDuMoXb1s3nTiHGLo0C/8jdpAW5kPzZgwBD4o1LlKI6ZcHHhzg73KQ6RXQ0ivNnHGSOsKWEDNbo8FayqyRrkSGZb75md6zxxaViKLzkgLBWjWSakQkmGKDQW/+nx8uvSI0Fa0DR8tbhNxb6igMqgW2OZoz061QWWlEiI6+lITMcKVIJKWYrnHLLkxDl0KctkyhKXcV9KY08z753rmjUshZBVM/PVzNzd78MVCBTAY/jDIz7xil884xt/ePjqXPCR57s7dYRrvO9gIUfZPOc77/nPgz70oh995/kUNXpXWvJkt/zkJzT427hAq3PpO+VXD9HLqx72gpB9V6KeezR7JvC1130feI8V3w8f+IDHffKJbwfjJ0Km0aR9PT45/cqvZPDCr4f0S+l8HUztUEdBgF9IIoc/xP5AvEd+7A10qfKnzgldpYs0/76p8RPBKvDQxcNI19V7tx6luP8f+QlE/KFf5K3f633f6cWAKXyIQ0xBEoyNmIzSLx1CtOjZY5VS+LnCA0KRBM6DCphHF5DSiaCIBm1DER0Q9vEMD6UCAnjCpSgGJjnTCfjK8HhdIE3KF3lgBDpLCN7SKI2gs8xWBgqd9y1gMAWSFXAPmf3KRcEgUTTBhVVEE+TNBurQNTDhEDhhIVjKKPgKivgX93yIYHwKyW1KChQEE1wOx1wEyzTBJpQTx5RaAkCXWUnZEl4BF56IFwJMFI4BFY7DFc5SEu4AB1IP94hKJVwUL6iCX7RCoV2ffClhqJmPFYkJ2XiFFXQGUpnhGbLgDcwHslHBURzAGzaMOJBMY6T/hO/oYOoBoNwoIibyhyM2AQRAIhNIIhIaYiziYalo0HrlSHyNgQA0gIGkAgSYQb1RYgMS0R7agDBm4jkU0jysAQScUCn9n+1Z2oxl0RtCxoApwAK4DiMc0fYJEzAagTRGVjEeozQoowEZUS8GASKGEF6RwcIRYxOERKPpkSsWIgPCwDUYixHIwTR6BbQM0OWkYkDqYwvaoDTwo6EpxjWIDXoU2Ey4lDMGoHwVpA0cZDvyIzYswT+antrQIxCEX/kIiqv5lKZQ0X/Uix2e5Ao240CypFroA0Jyj8AlgREQYj6gYekMAT9EBHWAoywGle9sggEUBh7uoKHk5Jm95DjE/ySsjAFN8mJK5iEObMMSNMbadd1kyQEqfcnV1SRqReUlxRVZWoMIhsReGd3bIRRKcmMHLQFHAJO95FJnnAMv3RYuQSUs/kJbip3TBeG+qMRZLlNajh1XDubvEWaGDKVjoKOPKGASQh9uUB9lhuLydeRg8JpmRlXvdSZmfiZlXKZoZuYC0go0MVQAfkddUoX9VR1odBJWXKYujYc8xsNoumamHNU5oQNZgeJNnkAoCIVe+Aw7qBlYpeaT+JHHQRF+QaI8pF8A9geMbVFbDcNz2iVkVmILbFmBkAYmxYnZzZYyNUu0TItmdcFv5ZYxQSdyOgvExNgKoCdtEeEJUp0x+f8KsJxWa/UW0SCUbSrkwtVHMv1KtfwlJkEPupCLZ/XVYJGBGfDJ9tXHw80gGvAnv7AWgDbovDxdgV7WPIrnePbYObzhAjhDHIxN2ZAZHMIMCNnMEYhYqxwU2nSkMeai+rnod40G2ZjNz0jRxnSM07QZgAQYfmmWWibiC0gQOTSACbKPtRDgjV4K2WyN0dBM0nxPeVnFgK4lYe4Or6hPJAQpjBLpzTmKASCpAHhMFQkJkzaBk84IcH6fpBDNTlSkxDxA8YSM4GTO5gTPneYM+xFeuqgfoApqRpKB4cwOqF0ZhtgmCkiSuA2cevRMlRrqEcCD69xjSS5Blg1jV5bpHED/gZ6ID2aYAgME6tIYD6RmEExM6rZ1iZ46X6UEy83VivUsSQGlqcxhD865Wnimqgq8G4m1KgFdE5EJkfXgY6XWZ2qRJy9kEBNGqWChTxa0mu5Yz4y9QldtH6kNa7MG67PGzSlIK65aamvuad8sqCs0RLqpW0SaELQY636wX1yugoWYQr0SUY6UEA21nbtWq/K9jllo67IuXFEVLEXCRNvNkHmVWuthSUnZEIcqi8B+AsGeUKkcbDXkKrzuarLwkXocSjm5AlD8kSKBKxlhUZ6Nw/fUJPst5f6No386HMtC0ssOY39IkRXw0bZJ3HVGmcK6xMYdlhMsCYCwj6rdHBrR/6wW+FEilaFQoIGpIkGMJCuz7oscBQZ6dGd1QIDPOi3QhoPQ7pEVVcPRomiKDmSyGJ2DrNLRIVZvfoLR1R1pyaOiAiYrgaV93O1s3pbf9tJhth19QqksssB3GGZuso9gVh3R7e0uGdPVhQRsfu2ZcO6TNAgTFC5sKobkpoLagVbVxYquEh/0beaunWZkJsOlvhE+rKaKogPr6h707SU+KGoO9G7uVib4ZcTtnpJjjoTJtm5pHl/s/gXtDobx1oXuwt7rzpTz7gX0/oX0XobcciROoSrmRenthebzKu/uuh/pqe/6sq/6sooAtm/8yq/8vm86zO/94m/ojQL85m//9v9v/XpvYTreABNwARtwXX6lASvwAi9wXTLwA0Nw45leAkdwBVcwbQZwBmvwBnNwB3vwB4NwCIvwCJNwCZvwCaNwCqvwCrNwC7vwC8NwDMvwDNNwDdvwDeNwDuvwDvNwD/vwDwNxEAvxEBNxERvxESNxEivxEjNxEztxDUeLipApivHsYz7xFbuGdWyFAqTlR4SBkrzAPAyNJgrRNmLxGW/vCBxFHpykVVwBBrOEc6DxHFfICOxLxgUC5agxF/SAgXCBxxmFqmFjjDzNFG2Fxx2FwGQcARAgSeVJD1CBszCAMkIAMtDxJQ9Db0zWCHCBOf7BnvSxFFmFNIwADF6FGFv/wSEHhB0XSFlM8jLOg4EoYxLMAMkogDBgci47gibLjRn8gbW4QUqMMm+A8TBbGiwvI0l8hR3rAi808xEsYyGQwjEkgLzo8jUnAi+nwkaghA8Y8zAbsxhD88HJ8SkMkBwPszgP85SQAPNi8ztXhx1bLRj/gV4o1jcXMxiP8z4rcy8rRFnYIECrMxiPhjXFIzwjdB1ocSknBFmUBRtAQOLITz6LETL/gFYwrTk7yyy/cogsYzr70QAoIxwndEmLIOdtWSQsciVXAXUaRUC8NHrwWCE7yyIXiSsYwCI3Mk3HtJ6Usm+adFAL9VATdVEb9VEjdVIr9VIzdVM79VNDdVRL//VUU3VVW/VVY/VrSCuKqIuE7gvnIMFGZvVYl44POEUPVMKHKAnHkXVbb8p89HMPLMwxIKZb2zX7OMqdOkcPGIUZJPBdA3Yvb56QbAUkj7N1BHZgy3MBLgk8aAUvLHZiu3Vk9/MnQDJJmLFkT3Ui9woZfwJYp7Rmi/Zok3Zpm/Zpo3Zqq/Zqs3Zru/Zrw3Zsy/Zs03ZtJ/GIWt+fnS8Ie+0Hxgs/IK1KUpcR5LZkM3JC6C71avDmHqDSuAQv7EmpkLQfnEa7ubU1p4OvaJBRIIVCfEF6qBEeLURM2IndHOsLw6krfEc4WBkw3hlJuRScioKRucoPnOJRqMXY+I2rTP/rWC9ybycirBjB0lCEkBwOGjQM1IJQSICQcqcokXAxLYXZuVJOQii4LUyEKSRAjEyQdY+1QzOCO4WhpN1X/plqUfDD/jo4ZI4jQs1NqFH4icehtR3lrO12SZfBCLiF4w6FDZyQHkCCo6lCUiCqDEM4p76OQ7i3J1yOsnRDjozBASCD+qw4Qj9AW/gJKtjhy63BT5o4Uwx5ATzNebtweo8vkTw3TJiHqFpbBkrSukzGCVBJsPW3aEPGcUnBkoALPIBngjynUaBUQBgnDYeE5pFxBP42zYig5fhVQMgQyUwhJwRGoD7EYNu2UcvLxMDppVc1i4GkCnJ6qIv6qJN6qZv/+qmjeqqr+qqzequ7+muoC1C/gIoUop14p3eAlqwnbF1ozSe47E2EmOlF0E6FmF8YOnUFQbk57o2/8yQowHTPOrS3RDbWZ3Ez415o3uusw3FpDibt+AFM8lJogwStiMlKORxldlBjt01WUX2LAjJEUcPEWLklCM0MbU5ExCgA8D/LUXnr0dXsLzlKEVm1e0zcN3VGQk5kgYfZIDz8hx/VKcSPjas4xI0peyIYQIDBREKwDrxhQ79sA+SlSmoUvDG6TXLmhEqMKCUAYbqX9H/bpSZmjaXZ1Yo4Onqsw6ERRamASxJ0+HGgAoPbAkg8yVx5WBaAUIbfx89rkHQ5yZMY/wU51IRa+FDP34JFasqxzYhYlNAUjEK/yHyC8zHceIJ95YjLIzSI43J8Pfm4ako08LfbJ+P4vRWloUJOb6mt+NHBRZqxQmurNn3olAOtSZg2iF/eywLWj4PWc3eiXIQHpsDTp4pSaL2qcNupInWOb0XMG+GhzVeLgJebQXlbnWuOQJcpZHxBSI/fryuVs1urQKLZg4+zOBAU3PouQwZ4dfzgdOOKWrZY10fbQxpTRDhGoALaWzmWc357HNpooJQVHITJeD42rAOZzDnJwNGcj/kAKNaevIQUtIqbr8O6qKF5YP86doHJLIRiFc4oxQHiNI2lVb9Y7x5kJJKtZEG3a/9rde0LCCAJQALPUTRPSQYCIAStYCzFsbwy+TQwQQKyhsSi8YhMKpfMpvMJjQ4TgcCIYQAYGCQsgKCwkqiKxzW7AxQYgYZD2yiPWDtDO8F9VN+F8CFxpsXV1zCQRmIQpzAAAAgTIDfW9ibQ0PBiEKZQoMbmJoXEVpXVF8BI4tCWNWRXxdVaNeLQELAy5LXVlZU6gCCQYEtimNpSJQaKnKy8zNzszCL0LG1wAMBwWiJQUOAi7f29/IaTUg1ufo6ert6yjhxjSqQX8NZenx7WkLVqz9/v/w8woMCBBAsaPIgwocKFDBs6fAgxosSJFCtavIgxo8aNHDt6/AgypMiRJEv/mjyJMqXKlSxbujw3IGYCTgD+FImJpMC+l+iCZQrAgCaAWYeiCOBSAqeAFzybMiGw9MGCLDaJ4DwSwykzoSwEKIjmIAsDBcI2cY2iYCfOq1p5UjsSrYagRggCIMhiqMGCOQwQiACgAIIVbnazJPBbtO3NeUMOCIiWbQeEs4gUNECggEqOmsaQciMhoO4CRmwVs2xAgECwIZB9ZaU5C8CAQZMfnFrgeMelmgu+cNppusiBXg+4QiaxCMYCY+VAI+D0N/anrI1sTZZNGlvwlAZSE4BgBLKLrInsyrjqwnwACEt3EDAG5PIAptuRBOhd4vhh0DsekI08wyNf8NcCJ9St/6VdfSYd4B1+RERTQG9ZQZBFVlfdxRiAvrHyAATNKVjCcAgUBw0Lh9FkAAIEathNVkJkdYAPAmJHI4godbhZEUKkOMKEBqxxHlkC9OYAAtWEJdcaZq0wwDZT2ZhUhqyVcCILCLyhQlc7tChDloaYQA8AFKaQHZRaGaMAU7nY0QAejWhSDlFBycaYPCvIEyaUlDVizBXG7FDKanNZo88gln2pYgmJREKFMWY+CulEb12TSaSWXprRO4yggGmnnn4Kaqiijkpqqaaeimqqqq7KaquuvgprrLLOSmuttqqUAC0qFPBYgt84tqdsUNkDLBO8fnhrskR8NVpgSxHgqzcDDP97E7XtTEtfEr0qyy0rBNhAwgGOQWvNDmwIs8C3DqTwHVKhpSaDHe2yUAMBCHCRQLp3CYtJAPNSkUBm9dorFlAQQDDHAOkusO5XBDQgVL33auEvBFzEmNpdCHybWLe2TsvIUtps628LQCQAhgAxoebAtCtAkIMDZEHgy1dhHuCvwA8PCR62YtZMQMscJ2DAfCj7kDMD3zWS8soQOPAAAUhxBsYINHsVNMtHZfJetB7TCvIXqT3LSMkAlOyvUO8FIcPGyznw2HIba+dz3VBhG7dd0PqshgLprm022gSoLZi/h/ic99xKCxYyuV9z2x1+/pJ99uCVA4AaTQfQrMbDNfn/BwEBR4v8oc9Rv6F00VB1d8lSw1HL8hcyBB6f5TXBLLJaw7JOegF4pPvAto9zy6zCUG3L7MZAOGCvIbNJHTsEiyDg4caLFMJC1CpsjsAAnPts/QCF8I3aWIALUTLz3ZuitCmWZf/wCuEX0ob4QXc38fDK5tpGcXaMEKhzwQAfWdDDJ0xQhbSoQR4KLEEpGPGTOVGBFAw0wARJkAJTAKVcXdiBV1TRCF3l6YELTKABiHLAvOhvhSxsoQtfCMMYynCGNKyhDW+IwxzqcIc87KEPfwjEIApxiESMyADosZRmlKZUghqKmmiRJ6NMjUZJLGIz7MWJJSJDi56iCdamAIHb//wIN8hooDDKZMUmvCU8CSgTLAzjHyxYBjOaecFhClMjUP0kXI+hF1A2lSgGzKEyl8nMfV6AM1dg0IOiQWMalYAa1YQHAM/ByW4qIRuGGSA00JGFD2DjAy5GKldmDEKIKhmyHZSGk5T0JOYosQNgkOA6CHqkErqTGvDoqBExYUQ0gHAV6nAJDubJI6b8hixTtgAvqTyjlgLkohUFwECqdKQtjcCg1DhoSpS8hpho0rNTCPMFPhKQKCFFSuBEwxgL2MsBAjnIGQ3zRTKI0YpqeU0k4ChbJWpEGAFDGrIEc0vklMGYznXOSO0xP1YRY4Q+NE4BeUkGDwjTmLCX0HwqIf8NbVKD8zjhiEHh4hV3wFc8QUWTRh1jDHMoTxRzQai5EAJR9IqDGfjkKI3qVBmTGkCldgrUc2iqJsEKqlGPitSkKnWpTG2qU58K1ahKdapUrSpVVTafZCQgmUbI6HGe8SMjdKMhTYQbIqDYBN8pKgyD1IMCuOqEI9LBjnDN4QEU8Fat1nUIXjXHWInw14Ds6Ysm+icApvLQnEgiDWOqkw+KlIxElaAbgZ3hGm9yCgawIQeXkZEGn2ONukwzpvMIgAFSVAUDNXIIDxBtFk42hzrUxUhvpEtduuCXeBqAZufxyym6cZiJbQFRdkEKUO7zm9mioAr7esIwGtNHRf2xJvD/NAIvEKGHFcVmrM0dw2bxgFwYiHYOR+FBXdhzNn7GMJJNdObZZAHafRGgGrNRQxdW0A2paQNcAfumMVMUIGCeQggUUkOMyOkDyxXwNh/qhh2Wmd4HAyYBAoBA8OxLyddWgwEvI8WBeRMFEZGIoeFC5YyWWAA9DACiOxiHgMoQoKSQpQDztcbLsngKBQI4vTymIS6XhlloEnRAAkrFfcr2ghcVri4Hottvk1wjIFBHmQOSjw5Ei97JvuAqOHGBwqowmikbYj1Qxs6UZVeFrzrhPv08GzNPnKDlFGHKrXVUIg/JgqsIISZNVkM1A1RZGGbzW119sjzLPIsa4JjHL5Is/5zzbGgBmzI0LLiOmLDrISkNoRsPQMoA8KuyKVKnBwE+I6XzU9QliNg4kwWzO6vLghSbgsVWWU2E+DpgU/9ZljWirHphuM9CCznAKGiTonGGZCJTcgU2uah2jr2Zk/kAZSRgGAwyEVDZOOmERhrKTtp0A9zgoBouwAEm4NYfHwypzDixNg3Gso32JuG5D2potccI1+uuyL5Dosk2kgNpZeLE2ZhDkQ3M3eMfNioQMPUCGI5Bhpt6IQ1A+sSibsoCXvjibMgpbbjCEJQCfBSBGZITVxKhbkswBReaOO3U2DAbNLC0JiDnhJ2gsCeVxjOkLk0CTURhWj4xoDl3IEJIY/85gkUtwp4l4IUXgD5FW6q5GeIAFw+1wQ0BYPypHWsGAX2IJy1YdexkL7vZz472tKt97Wxvu9vfDve4d6qXMwnXSd1rBJ2wiijBMMQmzqppKQa8ilQ9nlSocndjEuHMKC3CVrkxglyZ4D+IJSMoSonPpF623ojoTS7uuK+87AW3fwnMYJhrGMRAit72VgAfevPOLuh2jobczJ09w8gjKz6o7J1kCVwjA1DKhjYpZjB1doODDQHHRqsewmbGKuU/ZyO+rpxOLK2z6Iza8se65PwMyEOL26InBlhuD9vSjLnu/RpKbC6BAozLlOjj/dAComeBHq39Rw56m22+dTktdAqxGJIn1GE7itIhe2UazYcc/wEYr0ddsvdMPBZNAsJ0fZZ/jxRsu6QFf+EjQCIbQkIk3YYkvaEk8aZtEbJ89cF6C2giPuAf95ZYLFJQmMMkFGVRP4JRXuNUaKImJNUm+AInqEALc/JcNxd2j7Inf+JpkIAiaEUvSDFSfUM/lFRTjPInchdEPfVTWKhTQ8UpXAiGYSiGY0iGZWiGZ4iGaaiGa8iGbeiGbwiHcSiHc0iH5xACADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John Vella, MD, FACP, FRCPI.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_28_24015=[""].join("\n");
var outline_f23_28_24015=null;
